Although there are only three models on sale at present, its M5/M7/M9 models are the top "players". For example, can you imagine a large SUV with a price of more than 470,000, but in May, it obtained the report card of sales data of more than 16,400 new cars? Therefore, with the empowerment of Huawei, the brand of the world can indeed be called a soul, which is exactly what other car companies envy.

No, after the new model, the new model and the customer M9, the customer brand will soon launch a brand-new customer M8 model. The new car is expected to provide a 5/6 seat layout, and the price we guess will start at around 350,000 ~ 400,000. If the price forecast comes true, then there will undoubtedly be opponents in this price range. Let’s take a brief look at it.

Judging from the spy photos exposed, the appearance of the asking world M8 is basically the same as that of the asking world M9. It is also an iconic family-style front face design and a penetrating taillight. The overall visual perception is not much different from that of the asking world M9, but it is slightly smaller than that of the asking world M9 in terms of volume sense, which is also the reason why the positioning of the two models is different.

The picture shows the M9 extended range version (left) and the pure electric version (right).

As for the interior, the M8 is expected to adopt the same interior design as the M9. The center console is composed of a large LCD screen, which looks highly integrated, and the interior should also be equipped with Huawei’s latest HarmonyOS cockpit.

Other configurations, such as rear projection, car refrigerator, 25-speaker HUAWEI SOUND sound system and ADS 3.0 smart driving, should also be available, so I don’t think friends who care about configuration and functionality need to worry too much. This M8 can definitely give it to you.

In terms of power, if there is no accident, the M8 should also provide extended range version and pure electric version for selection. Taking the M9 as a reference, its extended-range model is equipped with a 1.5T turbocharged engine and two front and rear motors, with a total power of 496 HP and a total torque of 675 Nm. The battery CTLC has a pure electric cruising range of 225km and 275km.

The pure electric version of the M9 is more simple and rude. The total power of the dual motors is 530 HP, and the maximum torque is 673 Nm. In terms of battery life, the CLTC of the pure electric version M9 has a pure electric cruising range of 630km and a battery capacity of 100kWh, using batteries from Contemporary Amperex Technology Co., Limited. However, there are only two versions of the pure electric version, and the lowest starting price has reached 509,800, so most users may still buy the extended-range version.

Finally, there is no doubt that the market share of the ideal L8 must be threatened by the arrival of M8. After all, regardless of the price, size, configuration and power form, the M8 seems to be chasing the ideal L8. Therefore, if this new car is really sold at a price of less than 400,000, then the ideal L8 obviously has a strong opponent.

In a word, the brand of Jiejie, which is empowered by Huawei, has already begun to show its edge. With the coming of another new model, Jiejie M8, we also believe that the new car will definitely catch fire after it goes on the market, don’t you believe it? Then let’s wait and see ~ (Text/Youshi Automobile Dazhuo)

Note: The pictures are from the Internet, and the rights belong to the original author. If there is any infringement, please contact and delete them. Thank you! This article only represents the author’s personal views, and does not represent the position of AUV.

I. Basic financial data

Data is rounded to see more financial data > >

Second, the dividend delivery scheme

Rmb 0.130 per share

III. Business Review and Prospect

　　I. Discussion and analysis of business conditions

　　The year 2021 is the year when China has built a well-off society in an all-round way, and it is also the first year of the 14 th Five-Year Plan. Standing at the historical intersection of the goal of "two hundred years", facing the global COVID-19 epidemic and the national joint "purchasing with quantity" environment, under the strong leadership of the board of directors, all employees of the company actively responded to the risks and challenges in operation, forged ahead, continued to reform, accelerated the research and development progress of new materials, new processes and new products, and actively expanded new pipelines to adapt to the new normal of epidemic and centralized procurement.

　　

　　II. Description of the company’s main business, business model, industry and R&D during the reporting period.

　　(a) the main business, main products or services.

　　The company is a leading orthopedic medical device manufacturer in China, and its main business is the research and development, production and sales of implantable orthopedic medical devices. The main products are joint prosthesis products and spinal implant products. The company is one of the enterprises with relatively complete medical device registration certificates in the field of joint prosthesis in China, covering four major human joint prosthesis products, namely shoulder, elbow, hip and knee, and spinal implant products are a full range of product combinations of spinal internal fixation systems.

　　(II) Main business models

　　Based on the regulatory laws and regulations of the medical device industry, the national industrial policy, the industry competition pattern, the upstream and downstream development level of the industry, the market operation environment and other factors, and combined with the company’s own development strategic planning, resource factors and technical strength, the company’s business model is determined together.

　　1. Purchasing mode

　　The main procurement contents of the company include three categories: the first category is raw materials, mainly including ceramic blanks, cobalt blanks, titanium blanks, polyethylene and so on; The second category is energy power; The third category serves external processing, mainly including spraying, basic machining and sterilization. The company set up a purchasing department to take charge of the procurement of raw materials and outsourcing services, and formulated a perfect workflow to ensure the efficient operation of the business.

　　(1) Procurement process

　　The purchasing department of the company shall be responsible for making purchasing plans, preparing purchasing orders, transmitting purchasing information, signing purchasing contracts, checking raw and auxiliary materials and establishing purchasing records according to the purchasing needs of various departments.

　　In terms of finished products and raw materials, the company’s procurement process is mainly carried out by bidding. First, the purchasing department conducts pre-qualification and selects three or more qualified units or suppliers to invite bids. Then, the purchasing department and the person in charge of purchasing control the bidding process and select one or more successful bidders for cooperation. The procurement contract drawn up during cooperation should include the necessary clauses such as quality constraint, time constraint and liability for breach of contract. After the contract is approved by the company, sign a purchase contract and quality agreement with the supplier, and ask the supplier to issue relevant certification materials. After the goods arrive, the quality department will control the quality. For outsourcing manufacturers, the company strictly controls the quality of outsourcing products and services by establishing and strictly implementing the selection criteria of outsourcing manufacturers and regularly evaluating outsourcing manufacturers.

　　(2) Development and management of suppliers

　　① supplier access and evaluation mechanism

　　The selection mechanism of suppliers shall be implemented in accordance with the company’s bidding system. Suppliers must have business licenses, legal production and operation certificates, quality management system-related documents, performance and safety evaluation materials of purchased goods, self-inspection reports of enterprises or effective inspection reports issued by qualified inspection institutions. Subsequently, the purchasing department took the lead in organizing the production department, R&D department and quality department to jointly invite tenders, and the suppliers who passed the evaluation were included in the List of Qualified Suppliers, which took effect after being approved by the management of the company.

　　② Quality control measures for suppliers’ supply.

　　The company agreed on matters related to quality compensation in the contract and signed a Quality Agreement with the supplier, binding the quality responsibilities of both parties. If the product is unqualified due to the supplier’s reasons, the supplier shall compensate the buyer for the losses according to the agreement. The company conducts normalized quality communication with suppliers to find out the reasons for unqualified raw materials and ask suppliers to make improvements. After the supplier improvement is completed, the company will check the effectiveness of the improvement, and the company will terminate the cooperation relationship with the supplier who fails to improve as required. The company conducts regular on-site inspections or temporary spot checks on major suppliers, inspects the supplier’s production process, ex-factory inspection process, personnel and equipment and corresponding process records, and judges whether the supplier has quality management capabilities, thus ensuring the quality of supply.

　　③ Settlement mode and settlement cycle

　　The company checks with suppliers every month, and after checking with the system, sorts out different types of business payment documents, which are approved by department managers and company leaders and then transferred to financial personnel for review and remittance.

　　The company settles accounts according to the payment time agreed in the contract, and suppliers with long-term cooperation and a certain purchase amount have a certain credit line.

　　2. Production mode

　　The company mainly produces based on strategic planning, market demand and annual sales target. With the cooperation of relevant departments, the production department carries out the established production and processing tasks according to the production plan, ensuring the company’s annual supply capacity and ensuring a certain safety inventory.

　　The production department tracks the orders received by the sales department in real time, and makes a production plan according to the sales volume in previous years in combination with the company’s safety inventory standards. After the production plan is determined, the production department issues the production task list according to the planned progress, and then enters the specific production process. After picking materials, the production personnel gradually carry out machining, polishing, lettering, cleaning, aseptic treatment and other links, and finally complete the warehousing. The production department of the company strictly implements the system related to production safety. In addition, the company sends safety personnel to supervise and inspect its work, strictly implements rectification for violations of rules and disciplines, and strengthens on-site management and hidden danger investigation to ensure the elimination of hidden dangers and reduce safety accidents.

　　The company’s main production modes are as follows:

　　For products with many varieties and small and medium batches, the company adopts the unit production management mode. This model has the advantage of high efficiency of assembly line production, and can also adapt to the changes of product variety and quantity quickly. The unitized production management mode is mainly composed of two parts: production unit and management unit, in which the production unit takes products as the center, centralizes the layout of equipment with different functions according to the process flow, and creates hardware conditions for realizing continuous production flow; The management unit carries out a series of management optimization around the planning management, personnel management, material management, equipment management and quality management of the production unit, so as to shorten the product delivery cycle and improve the production efficiency on the premise of ensuring the product quality. Under the unitized production management mode, the equipment, personnel and materials are reasonably allocated, and the production mode of "one person and multiple processes" with the goal of "one flow" in the unit is conducive to shortening the processing time and production change time of products with many varieties and small and medium batches.

　　For products with few varieties and large output, the company adopts multi-product batch production mode. In this mode, most products are designed in standardized modules, and the parts are universal and standardized. Employees have a high degree of division of labor and high proficiency in single process operation; Metal die casting, precision casting, die forging, precision forging and other methods are widely used in the production of blanks, with high precision, small machining allowance and high material utilization rate; The production line mostly adopts special and efficient equipment and process equipment, and repeatedly produces one or several similar products. The production process is mechanized and the production cycle is short.

　　For products with individual special requirements, the company adopts customized production mode. Customized production is based on modular design and standardization of parts. According to the special needs of customers, combined with the application of new materials and flexible manufacturing, it carries out secondary development and reorganizes the product structure and manufacturing process. This model not only meets the demand of customization, but also helps to reduce development costs, improve production efficiency and shorten delivery cycle.

　　In addition, the company introduced automatic production equipment in some production links to further improve production efficiency. For example, the company introduced intelligent grinding and polishing automation equipment to grind and polish the femoral stem, ensuring the accuracy of repeated positioning, while the built-in service information system can monitor the feeding of the moving machinery, and the motion control technology can also optimize the performance of the machine.

　　In addition to the above-mentioned self-production mode, based on the existing production capacity and cost control, the company entrusts some production processes to outsourcing manufacturers with corresponding qualifications or conditions for production, mainly involving product spraying, sterilization, surgical tool processing and so on.

　　3. Sales model

　　During the reporting period, the promotion of the "two-vote system" policy has brought certain changes to the sales model of the company and enterprises in the same industry. Before the implementation of the "two-vote system" policy, most enterprises in the industry mainly used the distribution mode to realize the professional division of R&D, production and terminal sales, that is, the manufacturers of orthopedic medical devices focused on the R&D, production, filing, registration and marketing of various orthopedic implants and instruments and tools, and the professional dealers focused on cooperating with the manufacturers to complete the marketing, terminal channel construction, sales and distribution, follow-up service for end customers, and operation follow-up. After the implementation of the "two-vote system" policy, the traditional distribution model was challenged, and sales service providers began to assume the responsibilities of some traditional distributors. Medical device manufacturers, distributors/distributors and sales service providers participated in the product sales and supporting services.

　　The sales modes of the company’s main products include traditional distribution mode, two-vote distribution mode, distributor mode and direct sales mode. During the reporting period, the company’s sales model was mainly based on the traditional distribution model. With the implementation of the "two-vote system", in recent years, the income of the company’s two-vote distribution model and distributor model has increased year by year.

　　(1) the traditional distribution model

　　During the reporting period, the traditional distribution mode was the main sales mode of the company. The main criteria for the company to select a distributor are that the distributor has the qualification for operating orthopedic products stipulated by the state, and the past financial performance and legal compliance of the distributor need to be investigated by the company’s background and field investigation. Due to the different amount of hospital operations, the company has no uniform minimum absolute sales requirements for dealers, but for dealers in some areas, the company will implement a rebate policy when their sales reach a certain target. The company makes full use of the distributor’s sales network and geographical advantages, constantly tapping potential customers, enhancing the product marketing ability and expanding the market share of products. The dealer agreement period is usually one year and is renewed every year.

　　Under the traditional distribution mode, products are sold to terminal hospitals through traditional distributors. Distributors undertake the responsibilities of channel development and customer maintenance, and provide follow-up service and other technical services including preoperative consultation, cargo transportation and equipment disinfection to end customers. At the same time, the marketing team of the company assists distributors to jointly complete channel development and customer maintenance by providing some technical and professional support. The business process of the company’s traditional distribution model is as follows:

　　Under the traditional distribution mode, the company’s payment system is assessed according to two standards: credit period and credit limit, and the payment is required according to the standard that is given priority. At present, most dealers expire the credit line first. After the credit line expires, the company stops the delivery, and the company will deliver the goods after the dealer makes the payment.

　　During the reporting period, the traditional distribution mode of the company was buyout sales.

　　(2) Two-vote distribution mode

　　Under the two-vote distribution mode, products are sold to terminal hospitals through two-vote distributors. Among them, the two-vote distributor only undertakes the functions of channel development and customer maintenance with the assistance of the company, while the follow-up service and other technical services are undertaken by the sales service provider. The business process of the company’s two-vote distribution model is as follows:

　　(3) Distributor mode

　　Under the distributor mode, the company’s products are sold to terminal hospitals through distributors. In this mode, the distributor does not undertake the promotion service function, while the sales service provider undertakes the follow-up service and other technical services under the two-vote distribution mode, and also carries out channel development and customer maintenance with the assistance of the company. In the process of selecting a sales service provider, the company mainly considers the local end-user resources, past service experience, historical cooperation, service personnel’s ability and other factors. The business process of company distributor mode is as follows:

　　(4) Direct selling mode

　　During the reporting period, the company’s main direct selling customer terminals were major hospitals, and the company had long-term and stable cooperative relations with major direct selling terminal hospitals. In recent years, the company’s high-end products have been listed one after another, and the company has also carried out several direct sales of customization/assembly and standard joints in Beijing and other regions. Under the direct selling mode, the channel development, customer maintenance, follow-up service and other technical services of the company’s products are mainly completed by the company’s self-built marketing team. The price of the company’s products is confirmed according to the winning bid price or the internal filing price of the hospital. The business process of the company’s direct selling mode is as follows:

　　For overseas markets, the company may adopt distribution mode, ODM or OEM mode for sales according to the specific situation.

　　In addition, in order to further introduce magnesium alloy-related orthopedic implant products and expand the market of trauma implant products, the company entered into a cooperation and distribution agreement with SynteixAsiaPTE.LTD in August 2019 to obtain the marketing, promotion and sales rights of related products in China, and agreed to purchase certain minimum purchase quantities of contract products within five years. The contract is valid until December 31, 2024, but up to now, SynteixAsiaPTE.LTD has not obtained the medical device registration certificate of related products in China, so the contract has not been formally implemented.

　　4. R&D mode

　　The company’s R&D work is managed in strict accordance with the review principles of quality standards such as ISO13485 and ISO9001/GB/T19001. The specific process is as follows:

　　(1) Project demonstration and establishment

　　Based on the market research of the company’s R&D center, marketing department and other relevant departments, the company formulates the annual product development project plan. The R&D department formulates the annual product development/improvement work plan in combination with the annual product development project plan, market demand, product characteristics and technical requirements, and assigns the design and development project leader, who further clarifies the project name, project objectives, project significance, brief feasibility analysis and project planning time.

　　(2) Project planning and review

　　Combined with the actual situation of the scheme, the project leader further comprehensively evaluates the feasibility of the project, studies and supplements the product specifications, technical scheme, implementation schedule, main key technologies, risk analysis, etc., and arranges and summarizes the scheme and sends it to the department leaders for review. According to the specific needs, the project leader sets up a project team.

　　(3) Design, development and control

　　The project leader shall control the progress of product development/improvement projects as a whole, complete product development and product design change projects according to the requirements of quality system documents, and ensure the standardization of documents, processes and operations. The units of the design and development folder should at least include design and development project initiation, planning, input, output, verification, confirmation, conversion, etc.

　　In this stage, the project leader prepares the design and development input list, and then organizes relevant departments and personnel to review the design and development input.

　　(4) Verification review and registration inspection

　　The project team conducts mechanical and biomechanical tests according to the test plan, and verifies the products according to the relevant national standards, industry standards or company requirements.

　　After the company’s internal projects have passed the verification and review, the project team will prepare the relevant technical requirements documents for medical device products to be registered according to the specific requirements of relevant regulations, prepare samples for registration inspection, and submit them to the medical testing institutions recognized by National Medical Products Administration for registration inspection in time.

　　(5) Clinical evaluation and research

　　The project team and other relevant departments of the company jointly formulate the clinical evaluation plan, and determine whether the product needs clinical trials according to the product characteristics. For the products listed in the Catalogue of Medical Devices Exempted from Clinical Trials or evaluated by clinical trials and usage data of the same kind of medical devices, the company conducts comparison tests of the same products and compiles relevant clinical evaluation materials according to the relevant requirements of the Technical Guiding Principles for Clinical Evaluation of Medical Devices; For products requiring clinical trials, cooperate with CRO (Contract Research Organization) and other companies to take the lead in completing clinical trial plans and clinical trial summary reports.

　　(6) Application for submission and registration

　　The personnel in charge of registration in the project team shall compile relevant registration materials, register products and obtain approval.

　　(3) the industry situation

　　1. The development stage, basic characteristics and main technical threshold of the industry.

　　A. Industry development stage

　　Orthopedic implant medical devices is one of the important subdivisions of medical devices. Orthopedic implanted medical devices refer to the devices and materials that can be implanted into the human body through surgery to replace and support human bones or repair bones, joints, cartilage and other tissues, mainly including bone joint implants and joint implants, such as bone plates, bone screws, intramedullary nails, spinal fixation implants, artificial joints, etc., which belong to high-value medical consumables. Because they are implanted into the human body for a long time, they have a great impact on human life and health, and their value is usually high. According to the report on punctuation information, it is estimated that the market size of orthopedic implantable medical devices in China will be about 60.7 billion yuan in 2024, and the compound annual growth rate from 2019 to 2024 will be about 14.51%.

　　According to the different parts of use, orthopedic implanted medical devices can be divided into four categories: trauma, spine, joint and others. In China’s orthopedic implantable medical device market in 2019, the market segments of trauma, spine and joint accounted for 85.80% of the market; Among them, trauma is the largest market segment, accounting for 29.80%; Spine ranks second, accounting for 28.23%; Joints ranked third, accounting for 27.77%.

　　(1) Joint implanted medical devices

　　According to different parts, artificial joints can be divided into artificial hips, knees, shoulders, elbow joints and so on. Benefiting from the growing medical demand, the joint market has maintained a rapid growth. According to the punctuation information related reports, the market size of joint implanted devices in China in 2018 and 2019 is 7 billion yuan and 8.6 billion yuan respectively. It is estimated that the market size of joint implanted medical devices in China will be about 18.7 billion yuan in 2024, with an average annual compound growth rate of about 6.87% from 2019 to 2024. Due to the relatively high technical difficulty, complex production process and long service life of joint implants, the market for joint implants is mainly imported products, while domestic products account for a relatively low proportion.

　　(2) Spinal implants.

　　Benefiting from the increasing medical demand and the development of minimally invasive spine technology, the market scale of spinal implant medical devices in China is also growing gradually. According to the report on punctuation information, the market size of spine medical devices in China is 7.3 billion yuan and 8.7 billion yuan in 2018 and 2019 respectively. It is estimated that the market size of spine medical devices in China will be about 17.1 billion yuan in 2024, and the compound annual growth rate from 2019 to 2024 will be about 14.42%.

　　(3) Implanted medical devices for trauma.

　　The production technology of trauma products is mature and the market development is sufficient, which has maintained rapid growth in recent years. According to the report on punctuation information, the market size of trauma implanted devices in China was 7.7 billion yuan and 9.2 billion yuan in 2018 and 2019 respectively. It is estimated that the market size of trauma implanted medical devices in China will be about 17 billion yuan in 2024, and the compound annual growth rate from 2019 to 2024 will be about 13.15%.

　　(1) International medical device giants have more advantages in the market.

　　Although the overall gap between domestic medical device companies and international medical device giants is narrowing year by year, the problem of low overall level of medical device companies in China still needs to be solved. In the domestic and international markets, international medical giants still occupy the dominant position by virtue of strong technical strength, R&D ability, capital supply ability, brand influence and higher trust.

　　With the acceleration of import substitution, the market share of domestic enterprises has gradually increased. However, from the perspective of the market segmentation of orthopedic implants, the degree of localization of the joint market is still low, and at present, imported enterprises still occupy a dominant position.

　　(2) The industrial concentration of Class 2)III medical device enterprises has gradually increased.

　　Under the leadership of international medical device giants, domestic medical device companies, on the one hand, step up their technological catch-up and constantly narrow the gap with international giants, on the other hand, accept increasingly strict government supervision, while the fierce competition among companies continues to increase, and high-quality enterprises rise, making it difficult for some small and medium-sized enterprises to continue to operate and be eliminated. Generally speaking, the industry concentration of Class III medical device enterprises with high technology content is gradually increasing, and the trend of survival of the fittest, mergers and acquisitions is obvious. According to the Statistical Annual Report on Drug Supervision in National Medical Products Administration, by the end of November 2018, there were only 1,997 enterprises that could produce three types of products, which was 25.37% lower than the 2,676 enterprises at the end of 2013. With the backward small and medium-sized enterprises being gradually eliminated or merged, the concentration of China’s medical device industry will continue to rise, and the scale of enterprises will gradually expand. While broadening the product line, they will continue to consolidate and expand their own advantages.

　　(3) Domestic medical device companies are accelerating the process of import substitution.

　　Due to the lack of strict and unified standards for equipment industry and the influence of municipal/hospital bidding mode, the medical equipment industry has been in a state of low concentration. Therefore, for a long time, many medical device companies developed in specific areas by relying on their special geographical location and marketing network. However, with the improvement of domestic innovation ability and technical level, the scale of domestic medical device companies continues to expand, R&D investment continues to increase, and the quality and approval number of domestic devices have improved, which provides the possibility for domestic products to occupy more market share.

　　In addition, hospitals at all levels have certain pressure to control medical insurance fees, especially the basic medical insurance system for urban residents, whose fees are mostly divided by age, and the overall amount is small; In terms of reimbursement amount, the reimbursement amount for urban residents is limited. Therefore, the long-term pressure of medical insurance fee control is great, and the increase in the use of domestic devices is an inevitable trend, which also provides an opportunity for domestic companies to accelerate import substitution.

　　(4) The development history is short and there are few large-scale enterprises.

　　The development history of domestic medical high-value consumables industry is only more than 20 years. In the field of orthopedics, the domestic manufacturers of orthopedic medical devices have a certain production capacity, and their products can basically cover various types of orthopedic diseases, and they have made certain progress in the fields of joint reconstruction devices, trauma and fixation orthopedic medical devices, orthopedic surgical instruments and spinal fixation devices. However, most domestic manufacturers of orthopedic implant consumables are small in scale, and their core products and market dominance are limited.

　　At present, there are few manufacturers of orthopedic implant consumables in China. From the perspective of enterprise scale, China’s orthopedic industry is still in a relatively primary stage. At the same time, because there is still a gap with imported products in prosthesis materials, prosthesis shape design, accuracy of surgical positioning instruments, joint surface smoothness, and treatment of contact surface with bone, the products of domestic manufacturers mainly focus on trauma and spine products, and the share of state-owned manufacturers in the joint market is relatively low.

　　(5) The competition pattern is scattered, and the trend of industry integration is obvious.

　　Because most of the manufacturers of high-value medical consumables and orthopedic implants in China are small in scale, the industry competition pattern is relatively scattered. In recent years, major market participants have integrated through mergers and acquisitions. For example, in 2012, Johnson & Johnson acquired Synthes, a Swiss medical plastic equipment manufacturer, and later joined DePuy subsidiary to become Johnson & Johnson DepuySynthes；; Stryker acquired China Enterprise Chuangsheng Medical in 2013; Medtronic acquired Kang Hui Medical in 2012; Xerox has successively acquired American sports medicine product manufacturer ArthroCareCorp, orthopedic robot company BueBet, and the BST-CarGe cartilage repair business of Indian pharmaceutical company PiramaHeathcare. The trend of industry integration is obvious, which provides development opportunities for enterprises with considerable scale in the industry. According to the report on punctuation information, in 2019, the top five companies in China’s orthopedic implantable medical devices market were Johnson & Johnson, Medtronic, Jiemai, Stryker and Weigao Orthopedics, with market shares of 17.24%, 9.70%, 5.97%, 5.19% and 4.61% respectively, totaling 42.71%, and the industry concentration increased.

　　(6) The demand for high-end products is still expanding.

　　With the increase of national disposable income, the increase of the proportion of the elderly population, the change of medical concept and the expansion of medical insurance coverage, the demand for high-end orthopedic medical devices in China will maintain a high growth rate.

　　After years of market cultivation, patients’ acceptance of orthopedic implants has been continuously improved. In the future, investment and mergers and acquisitions in the field of high-end orthopedic medical devices will increase, and good market prospects and huge growth space will bring greater impetus to the development of enterprises.

　　C. Main technical thresholds

　　Medical devices are knowledge-intensive and technology-intensive industries with multidisciplinary integration, and because orthopedic medical devices are directly applied to the human body, the safety, effectiveness, accuracy and reliability of medical device products must be guaranteed, which means that medical device manufacturers must continuously improve their technical level through continuous research and statistical analysis of large-scale clinical data before they can develop products that guarantee quality and meet customer needs. New entrants to the industry often do not have this technical level, and the difficulty of entering the market is further increased.

　　2. Analysis of the industry position of the company and its changes.

　　Based on China’s huge population base and the trend of accelerating aging, China’s orthopedic market is huge and has considerable growth potential. International orthopedic giants have successively entered the China market through local mergers and acquisitions or investment in factories. The period of investment and factory building is longer than that of mergers and acquisitions. Most international orthopedic giants choose mergers and acquisitions to open the China market.

　　In recent years, with the support of national policies and the opportunity of domestic market expansion, domestic orthopedic medical science and technology companies have gradually developed and expanded. The main domestic listed companies in the same industry mainly include Aikang Medical, (), Weigao Orthopaedics, () and Sanyou Medical.

　　The company’s main products are joint implant consumables. Because the artificial joint prosthesis needs to form a permanent combination with human bone tissue and replace the original function of human body, the raw materials of artificial joint must have better compatibility with bone and advanced bone interface fixation technology, which has higher manufacturing threshold and technical difficulty. Therefore, artificial joint is an orthopedic subdivision field with high technology content, high added value and high entry threshold. Due to the limitation of domestic raw materials and technology, imported enterprises still occupy the absolute dominant position in the whole market segment.

　　According to the report on punctuation information, in 2017, 2018 and 2019, the market share of foreign-funded enterprises in the joint implant device market in China was 67.88%, 66.71% and 65.06% respectively. The market share of local enterprises is 32.12%, 33.29% and 34.94% respectively, and the proportion is increasing year by year. Among them, Chunli Medical occupied 8.96% of the market share of joint implanted medical devices in China in 2019, ranking second among all local enterprises and fourth among all joint prosthesis enterprises (including foreign enterprises) in China.

　　3. The development of new technologies, (), new formats and new models during the reporting period and the future development trend.

　　3D printing technology: The company has introduced a variety of 3D printing equipment with different process types, and the "research and development project of customized and personalized prosthesis series products" is also in progress.

　　The company’s 3D printing equipment mainly includes EBM (Electron Beam Melting) equipment, MJF (Multi-jet Melting) equipment, and powder metal 3D printing equipment. Among them, electron beam molten metal 3D printer can melt titanium alloy powder layer by layer by using electron beam in vacuum to generate dense parts, which can realize printing of porous materials. Chunli Medical has mastered the technology of using electron beam technology to produce bone trabecula and other products. Multi-jet melting 3D printer ensures the fineness of the edge of the printed object by spraying solvent and fine agent to the laid powder, and then carries out thermal radiation heating again, so that the powder is bonded according to the model interface and stacked layer by layer.

　　Chunli Medical has mastered the technology of using multi-jet melting 3D printer to produce guide plate, prosthesis die test and other instrument parts. In addition, Chunli Medical can use the powder-feeding metal 3D printer to coat the surface of the medical implant produced by the traditional technology with the metal powder of medical institutions. The metal powder is uniformly melted by laser irradiation, and then cooled into a solid to be combined with the metal surface, so as to realize the porous structure on the surface of the implant and promote bone growth. In recent years,

　　Chunli Medical is developing a product called Advanced Customization and Individualized Joint Prosthesis based on advanced technologies such as China National Bone Database and 3D Reconstruction. Compared with the existing customized joint prosthesis products, Chunli Medical can more effectively analyze and meet the specific needs of patients. In addition, in August, 2020, Chunli Medical was hired as the drafting unit of the Group Standardization Technical Committee of the 3D Printing Medical Device Professional Committee of China Medical Device Industry Association, and participated in the formulation of the group standards of 3D Printing Tantalum Metal Hip Prosthesis, 3D Printing Tantalum Metal Knee Prosthesis, 3D Printing Tantalum Metal Personalized Bone Defect Filler and 3D Printing Tantalum Metal Spinal Prosthesis, and was rated as the "Advanced Drafting Unit of the Group Standard of 3D Printing Medical Devices" by the professional committee.

　　New material technology: the company has carried out research and development on porous tantalum materials and magnesium materials. Compared with other prosthetic materials, porous tantalum has a unique bone-like structure, high porosity is conducive to bone growth, highly interconnected honeycomb structure provides extensive bone growth, high friction coefficient provides good initial stability of the implant, and its physical and mechanical properties are close to that of bone, so it is an ideal bone substitute material. The project "Development and Clinical Application of Porous Tantalum Bone Repair Materials and Implantable Products" declared by the company was approved by the Ministry of Science and Technology as the key project of the National Key R&D Plan "Research and Development of Biomedical Materials and Repair and Replacement of Tissues and Organs" in 2020. In the "Tantalum Technology Series Product R&D Project", the company plans to prepare porous tantalum by CVD (Chemical Vapor Deposition) and produce customized porous tantalum personalized bone defect filler. At present, it has obtained the acceptance notice of medical device registration application issued by National Medical Products Administration; In the "research and development project of dental series products", the company plans to design customized and individualized dental implant products with porous tantalum and complete the production conversion, which is currently in the design and inspection stage.

　　Biomedical magnesium alloy, as a representative of a new generation of biodegradable biomedical materials, has received extensive attention in recent years. At present, the listed products are mainly concentrated in foreign countries, and the indications are narrow. Compared with other medical metal materials, magnesium alloy has obvious advantages, such as good biodegradability, biological safety and biomechanical compatibility. The mechanical properties are similar to those of bone tissue, which can be degraded after being implanted in the body, avoiding the second operation to take out instruments, which is beneficial to revision surgery and reducing the economic burden and mental stress of patients. At present, the company’s "research and development of new biomedical materials series products" project is in the design stage.

　　To sum up, the company has made great efforts to research and develop related emerging technologies as innovative application directions, and the research and development work is progressing in an orderly manner.

　　(IV) Core technologies and R&D progress

　　1. Core technologies and their advanced features and changes during the reporting period.

　　The company has been focusing on the research and development, production and sales of implantable orthopedic medical devices. After years of research and development, the company has mastered a number of core technologies, including general upgrade technology and unique technology. Among them, universal upgrade technology is a technology based on universal technology or necessary technology, combined with Chinese bone characteristics, clinical needs and feedback, to optimize and upgrade product performance or technology; Unique technology is the core technology realized by the company based on R&D experience and future R&D planning through continuous research and development by relevant personnel. The core technologies mastered by the company include hip joint core technology, knee joint core technology, shoulder and elbow joint core technology, joint bone defect technology and spine core technology.

　　The details of the company’s main core technologies are as follows:

　　(1) Core technology of hip joint

　　The core technologies of hip joint mainly include low-friction joint interface technology, personalized biological femur technology, press-fit biological acetabulum technology and hip joint revision prosthesis filling technology.

　　Advanced technology of low-friction joint interface: ① Low-friction joint interface technology refers to the technology of improving the reliability and stability of ceramic parts and reducing the risk of broken ceramic parts by optimizing the processing technology of mortar cups and lining used with ceramics, thus prolonging the service life of artificial joints. ② During hip replacement, the straightness and roundness of products used with ceramic components should be strictly controlled, so as to avoid the uneven installation stress of ceramic components during clinical use and assembly, which will lead to the fragmentation of ceramic components. ③ At present, the machining tolerance of acetabular cup and polyethylene liner of most manufacturers in the market is difficult to meet the precision requirements of ceramic assembly. The machining accuracy of the straightness and roundness of the locking structure of ceramic liner and acetabular cup of our company is controlled at 0.007mm, and the machining error in the product processing process is controlled through special tooling and fixtures to ensure stability and consistency, prevent the ceramic components from being broken due to installation deformation during use, and at the same time, the more reliable locking mechanism enhances the anti-dropping ability of the prosthesis. ④ As far as ceramic materials are concerned, foreign giants and major domestic enterprises all adopt CeramTecGmbH bioceramic materials; As far as processing technology is concerned, the company is reliable in straightness and roundness, and there is no obvious gap between the company and the highest level in the industry.

　　Advance of personalized bio-femoral technology: ① Personalized bio-femoral technology refers to the technology of optimizing the neck length, eccentricity, proximal and distal dimensions of femoral prosthesis based on the basic data of Chinese physiology and anatomy, and cooperating with the tools corresponding to the press-fit relationship to obtain better medullary cavity matching, stability and anti-rotation performance. ② Based on the basic data of the bones around the hip joint in China collected in the "Chinese Bone Mapping Project", combined with this technology, a personalized biological femoral prosthesis suitable for the physiological anatomical structure of Chinese people is designed, which includes two neck shaft angles of 127 and 133, and each neck shaft angle is divided into two eccentric distances, with an interval of 0.5mm as a specification; There are 4 models and 100 specifications, and the size interval between adjacent specifications is small, which is highly matched with the patient’s medullary cavity. At the same time, the prosthesis has medial and lateral grooves designed based on the different load properties between the proximal bone and the prosthesis, which effectively improves the initial stability and anti-rotation performance of the prosthesis. The optimized lateral shoulder design of this kind of prosthesis can also be applied to minimally invasive surgery.

　　The advance of that press-fit biological acetabulum technology: ① the press-fit biological acetabulum technology refers to improve and optimizing the acetabulum design, so that the "equator" position of the acetabulum cup is stressed, the force transmission mode is optimized, and bet stability, component connection reliability, wear resistance and the like are obtained. ② The press-fit biological acetabular prosthesis designed in combination with this technology includes a acetabular cup and a acetabular lining. The outer surface of the acetabular cup is composed of a spherical cap, a hollow spherical table in the middle and a hollow spherical table at the bottom in turn, and its total height is lower than the bottom radius of the hollow spherical table at the bottom. When the prosthesis is installed, this design makes the "equator" position of the cup bear force, optimizes the transmission mode of force, and increases the initial and long-term stability of the prosthesis. The connection mode between the inner liner and the outer cup is taper press-fitting and slot locking, and the plum blossom anti-rotation design increases the connection reliability between the parts and enhances the stability between the two parts. And the service life and wear resistance of the prosthesis are improved. This technology can realize the universal matching between mortar cup and ceramic or polyethylene lining, which is convenient for clinical use.

　　Advanced filling technology of hip revision prosthesis: ① The filling technology of hip revision prosthesis refers to the technology of optimizing the filling design of acetabulum defect, making the shape and internal structure of the filler more suitable for the growth of cancellous bone and improving the compatibility between the filler and acetabulum. ② The prosthetic fillers for hip joint revision designed by this technology include crescent, L, round and other forms. The overall mesh structure design of the prosthesis forms a honeycomb structure with internal interconnection, and the pore size of its porous structure can reach 500 200 μ m; The diameter of porous structure of trabecular bone can reach 500 200 μ m; The porosity of trabecular bone porous structure is 50~80%, which can make cancellous bone grow into prosthesis quickly and firmly, and the elastic modulus of prosthesis is close to the physiological bone level of human body. After the implant of prosthesis filler using this technology, it conforms to the physiological stress distribution, reduces stress shielding to a greater extent and promotes bone growth; Moreover, the filler can be compatible with the total hip socket and used in combination, which is suitable for cases with acetabular defects of different degrees and meets the clinical needs of patients. (3) Influenced by technological conditions, the related parameters of acetabular reinforcement, such as aperture, wire diameter and porosity, affect the bone ingrowth effect. Compared with similar products in the current market, the company’s hip joint revision prosthesis filler meets the requirements of relevant national and industry standards, and its porous characteristics can better meet the conditions of bone growth, and its specifications and models are richer, which is conducive to meeting the needs of patients with different degrees of illness.

　　(2) Core technology of knee joint

　　The core technology of knee joint mainly includes high polishing anatomical tibial platform technology, optimized femoral condyle anterior condyle and patella pulley technology, semi-open femoral condyle intercondylar fossa technology and diversified platform pad technology.

　　Advanced technology of high polishing anatomical tibial platform: ① High polishing anatomical tibial platform technology refers to the technology of improving and optimizing the design of tibial platform and adopting high polishing in the internal groove of tibial platform support, which can reduce the wear between the platform pad and tibial platform support and prolong the service life of prosthesis. ② Based on the basic data of the bones around the knee joint in China collected in the "Chinese Bone Mapping Project", the anatomical tibial plateau designed with this technology has better coverage of the tibial osteotomy surface, which effectively reduces the risk of tibial plateau sinking; On the basis of the original locking mechanism, the central anti-rotation island structure is added to further reduce the fretting between the pad and the tibial tray, reduce the back wear of the pad and reduce the osteolysis; The double-wing design can not only increase the mechanical strength but also improve the anti-rotation stability of the prosthesis.

　　Advanced technology of optimized femoral condyle anterior condyle and patella pulley: ① The optimized femoral condyle anterior condyle and patella pulley technology means that by improving the design of femoral condyle, the femoral condyle anterior condyle of knee joint is thinned, and the left and right sides adopt arc design technology, which can reduce the friction of anterior patellar muscle ligament, reduce the pressure and wear of contact surface, and effectively avoid anterior patellar pain. ② The optimized design of patella pulley can extend, deepen and lengthen the patella pulley in the whole range of motion, which is helpful for the patella to enter the patella pulley as early as possible, and makes the patient less prone to patella dislocation, snapping and pain after operation.

　　Advanced technology of semi-open femoral condylar intercondylar fossa: ① semi-open femoral condylar intercondylar fossa technology refers to the technology of optimizing the design of intercondylar fossa, reducing the amount of bone cutting, achieving the purpose of bone preservation and reducing wear. ② The femoral condyle designed by this technology adopts semi-open intercondylar fossa design, which solves the problem of large intercondylar bone cutting and preserves the intercondylar bone mass to the greatest extent; At the same time, the intercondylar box structure adopts high polishing design, which can reduce the wear of the platform pad column to the greatest extent.

　　Advanced technology of diversified platform pad: ① By optimizing the design of knee platform pad, diversified platform pad technology can meet the needs of different patients while achieving better stability and reducing wear. ② The products designed with this technology include the platform pad without cruciate ligament and the platform pad with cruciate ligament. Among them, the platform pad without cruciate ligament is designed with aquiline nose, which effectively prevents the risk of dislocation during high flexion; A double joint surface combination is formed between the column and the cross beam, which reduces the pressure of the cross beam on the column and reduces the wear; When buckling, the contact surface between the beam and the column gradually moves down from top to bottom, and when the buckling degree is large, the beam contacts the bottom of the column; Reduce the impact force and effectively prevent the column from breaking. However, the gasket of CR-type platform pad with backward inclination of 3 degrees is suitable for patients with intact posterior cruciate ligament and bilateral collateral ligaments. CR deep disc table pad is designed with 0 back inclination angle and raised back lip of pad, which is suitable for patients with functional problems of posterior cruciate ligament and bilateral collateral ligaments.

　　(3) Core technology of shoulder and elbow joint

　　The core technology of shoulder and elbow joint mainly includes proximal humeral prosthesis design technology and distal humeral prosthesis design technology.

　　Advanced design technology of proximal humeral prosthesis: ① Anatomical humeral stem technology refers to the technology of improving the anti-rotation performance of prosthesis and prolonging the life of prosthesis by optimizing the shape of humeral stem of shoulder joint, the structural design and combination of osteotomy surface. ② During shoulder joint replacement, the fretting and rotation of the humeral stem can easily lead to osteolysis and the sinking of the humeral stem, which will affect the service life of the prosthesis. Combined with this technology, the design of the proximal ellipse of the shoulder joint prosthesis can effectively prevent the fretting caused by prosthesis implantation and avoid osteolysis. The disc design at the top of the prosthesis will cover the osteotomy surface after the prosthesis is implanted to prevent the prosthesis from sinking in the later stage; To some extent, it can prolong the service life of artificial joint, reduce the revision rate and relieve the pain of patients.

　　Advanced design technology of distal humerus prosthesis: ① Anatomical distal humerus technology refers to the technology of optimizing the shape and width of the lower humerus, reducing unnecessary bone cutting and ensuring postoperative bone integrity. ② In elbow replacement, when the humerus side is treated, the two sides of the treated humerus lower end are easy to break, which affects the stability of the prosthesis. The elbow humerus handle designed by combining this technology can effectively ensure the stability of the prosthesis after installation, and at the same time, reducing the width can adapt to more patients and improve the application range of the prosthesis.

　　(4) Repair technology of articular bone defect.

　　Joint bone defect repair technology mainly includes pelvic bone defect repair technology, knee joint bone defect repair technology and customized individualized bone defect repair technology.

　　Advanced pelvic bone defect repair technology: ① The pelvic bone defect repair technology is suitable for severe comminuted fracture of acetabulum, revision of acetabulum with a large number of bone defects, severe pelvic bone defects caused by pelvic tumors, etc. The pelvic prosthesis can better achieve limb preservation, and on this basis, it can realize the integration of prosthesis, bone and muscle in the state of severe pelvic bone defect. ② The acetabular prosthesis designed with this technology can be fused with acetabular bone in patients, and the acetabular prosthesis is more firmly fixed; The range of acetabular motion angle is large, which prevents acetabular prosthesis dislocation; The acetabular prosthesis can be assembled at will according to the conditions of different patients, which meets the needs of acetabular prosthesis of different patients; Can save limbs for patients and meet different osteotomy positions in hip and acetabular surgery, the acetabular prosthesis is consistent with the position and angle of the acetabulum in the original patient, and the function of the human body can be effectively and reliably reconstructed; The iliac buttress is provided with nail holes, so that the prosthesis can be firmly fixed with human bones, and the bone contact surface is of trabecular structure, which promotes human bones to grow into the pores, and further improves the firmness.

　　Advanced technology of knee joint bone defect repair: ① Through optimizing the product design, knee joint bone defect repair technology can restore the flexion and extension, internal and external rotation functions of knee joint under the condition of a large number of bone defects, and fully meet the activity needs of patients on the premise of limb preservation. ② The knee prosthesis designed with this technology is composed of femoral condyle, tibial plateau support, femoral marrow needle, tibial marrow needle, osteotomy section, etc. The convex articular surface of femur is in direct contact with the concave articular surface of tibia, which increases the contact surface of the joint and restores the flexion and extension and internal and external rotation functions of the knee joint. One end of the restraint is connected with the femur with a transverse shaft, and the other end of the restraint is directly inserted into the central hole of tibia to make the prosthesis achieve maximum stability. Bionic modeling is adopted to fully meet the requirements of patients’ activities on the premise of limb preservation, so that patients can recover as freely as before.

　　The advance of customized and individualized bone defect repair technology: ① customized and individualized bone defect repair technology can customize the joint prosthesis by using advanced digital processing technology to better meet the special needs of patients. ② The development of customized and individualized artificial joints makes up for the shortcomings in the field of artificial joints, so that patients with rare and difficult bone diseases can obtain unique personalized prostheses. Combined with this technology, the joint prosthesis designed can be customized through the reverse use of three-dimensional data, which can solve the problem that special diseases need special-shaped structures and complex structures. Taking clinical application as the cornerstone, it integrates clinical, mechanical design, materials, technology, machining and other multidisciplinary advanced technical means to achieve the purpose of mutual supplement and mutual promotion between individualized prosthesis and standard joint.

　　(5) Core technology of spine

　　The core techniques of spine mainly include posterior cervical nail plate fixation technique, omni-directional large angle screw technique and anterior cervical fixation technique.

　　The advance of cervical posterior screw-plate fixation technology: ① cervical posterior screw-plate fixation technology refers to that technology of optimize the structure of the fixation plate, which can not only play a supporting role, but also fuse the bones, thus avoiding the re-closing of the door after the posterior laminectomy. ② The products designed with this technology mainly include fixing plates and screws. Among them, a porous three-dimensional structure is formed on the inner side of the fixation plate opposite to the cervical vertebrae, which can induce the bone to grow in, so that the posterior cervical nail plate fixation device and the lamina are fused together, which is beneficial to the support and fusion of the lamina and solves the problem of closing the door after operation.

　　Advanced technology of omni-directional large-angle screw: ① omni-directional large-angle screw technology refers to the technology of improving the movable angle of screw to facilitate surgical implantation by optimizing the screw structure. ② The products designed in combination with this technology mainly include nail sleeves, fasteners, washers, locking nails, plugs, etc. Pedicle screws can obtain a unilateral swing angle of 50 degrees, which makes the implantation of connecting rods more convenient and flexible, and meets the needs of alignment of most doctors in clinical surgery and anatomical variation fixation.

　　Advance of anterior cervical fixation technology: ① Anterior cervical fixation technology refers to the technology of reducing the notch of anterior cervical bone plate by optimizing the structure of bone plate and locking ring, and reducing the swallowing difficulty of patients due to too high notch. ② The products designed with this technology mainly include bone plates and screws. Screw holes are formed in the bone plates, and screws can be implanted into the screw holes in the bone plates to connect the bone plates with vertebral bodies. Locking rings are embedded in the screw holes in the bone plates. After the screws are implanted into the screw holes in the bone plates, the locking rings contact with the nut positions of the screws and expand to lock the screws in the screw holes in the bone plates. The original locking nail is changed into the current screw self-locking structure, which reduces the risk of screw falling off, and adds positioning holes on the bone plate to prevent the bone plate from shifting when implanted.

　　During the reporting period, none of the above core technologies has changed.

　　2. R&D achievements obtained during the reporting period

　　As of December 31st, 2021, the company held 49 registration certificates and filing vouchers for producing medical devices (joint prosthesis products, spine products and sports medical products covering our four joints) in China, among which 16 were Class III medical device registration certificates, 4 were Class II medical device registration certificates and 29 were Class I medical device filing vouchers.

　　In terms of domestic registration, the company obtained the registration certificate of single condyle knee joint and patellofemoral joint prosthesis. In terms of international registration certificate, the company has obtained the CE certificate of expanded hip joint prosthesis, CE certificate of expanded knee joint prosthesis, EU free sales certificate of hip joint prosthesis and EU free sales certificate of knee joint prosthesis, and obtained the registration certificates of hip joint prosthesis, knee joint prosthesis and spine prosthesis in Syria, Iraq and Ecuador, the registration certificates of hip joint prosthesis and knee joint prosthesis in Turkey and the registration certificates of tumor hip joint prosthesis and tumor knee joint prosthesis in Mexico.

　　The company has obtained the transformation project of scientific and technological achievements in Tongzhou District, Beijing, the transformation project of tantalum modified biomedical titanium alloy materials, the industrialization project of patented technological achievements in Tongzhou District, the key support project of high-tech industry development in Tongzhou District in 2021, the registration certificate of spinal fusion cage and hip prosthesis, the key support project of high-tech industry development in Tongzhou District in 2022, the digital workshop construction project of orthopedic implants, and the research of porous tantalum artificial vertebral body in Beijing’s innovative studio project of outstanding young engineers. Company Post-Doctoral Research Center obtained the general project of China postdoctoral science fund "Study on Composite Modification of Ceramic Surface of Medical Zirconium Alloy and Its Service Performance", the project funded by Beijing postdoctoral research activities "Design of Multi-layer Membrane Structure and Study on Friction and Wear Behavior of Tantalum Modified Biomedical Titanium Alloy Surface" and the open project of State Key Laboratory "Preparation Technology and Performance Study of In-situ Oxidized Ceramic Layer on Biomedical Zirconium Alloy Surface".

　　A number of products developed by the company have obtained Beijing new product and new technology certificates, including 160 femoral stem (certificate number:

　　3. R&D investment table

　　Reasons for significant changes in total R&D investment compared with the previous year

　　Mainly because the company attaches importance to the research and development of new products, new technologies and new processes, and continues to increase the demonstration of R&D projects, the investment in R&D personnel salaries and other related expenses has increased; Based on the national joint collection situation, the company has increased the research and development of new pipelines such as joint surgery robot, sports medicine, PRP and oral cavity.

　　4. Research projects

　　5. R&D personnel

　　6. Other explanations

　　

　　Iii. Analysis of core competitiveness during the reporting period

　　(A) analysis of core competitiveness

　　During the reporting period, the company’s core competitiveness has not changed significantly.

　　1. Technical barriers to product design

　　① Implants with appropriate size, shape and design can significantly increase the success rate of orthopedic surgery, among which the main performance of joint products is to require its wear resistance and stability of bone interface, so as to prolong the service life of products. Among them, the improvement of wear performance is realized by the selection of friction materials and the design of joint construction, and the stability of bone interface is realized by surface treatment technology and the design of handle, cup and other parts. ② As one of the earliest enterprises in China to develop and produce advanced joint prosthesis products, based on clinical needs and doctors’ suggestions, the company has continuously improved its technical level through continuous research and statistical analysis of large-scale clinical data, and mastered mature experience in product design and development, from product market research, project establishment, drawing design and parametric programming, to product finite element analysis, mechanical test, biological or zoological verification, clinical trial, product functional test, and then to registration application and trial production.

　　2. Technical barriers to product processing

　　① The production and processing of orthopedic implanted medical devices involves many processes, such as blank forming, machining, surface treatment, laser marking, cleaning, sterilization and so on, which requires high quality and safety of products. ② The company has a relatively mature and perfect processing flow, with traditional materials-reducing processing equipment such as turning, milling, planing, grinding and drilling, and materials-increasing processing equipment such as metal printers and resin printers, so as to ensure that the processed products are qualified in all aspects and accurately control every link in the production process. ③ The company has mastered some new processing technologies. The mesh structure of 3D printing products can realize rapid and firm bone growth. The company has advanced 3D printing equipment and mastered more mature printing technology, which can print biological prostheses with excellent performance. In addition, the company has initially mastered the chemical vapor deposition (CVD) process, which can realize the production of some porous tantalum metal products.

　　3. Technical barriers to research and development of new materials

　　① Biomedical degradable magnesium and magnesium alloy products: Biomedical magnesium alloy, as a representative of a new generation of biodegradable biomedical materials, has received extensive attention in recent years. At present, the company’s research based on magnesium alloy is being carried out in an orderly manner. ② Porous tantalum: Compared with other prosthetic materials, porous tantalum metal products have a unique structure similar to bone, high porosity contributes to bone growth, highly interconnected honeycomb structure provides extensive bone growth, high friction coefficient provides good initial stability of implants, and its physical and mechanical properties are close to those of bones, so it is an ideal bone substitute material; At present, the company’s research based on porous tantalum is being carried out in an orderly manner. The project "Development and Clinical Application of Porous Tantalum Bone Repair Materials and Implantable Products" led by the company was approved by the Ministry of Science and Technology as the key project of the national key R&D plan "Biomedical Materials R&D and Tissue Organ Repair and Replacement" in 2020.

　　(II) Events that have seriously affected the core competitiveness of the company during the reporting period, impact analysis and countermeasures.

　　

　　Fourth, risk factors

　　(A) Not yet profitable risk

　　(2) Risk of sharp decline in performance or loss

　　(C) core competitiveness risks

　　Orthopedic implanted medical devices stay in the human body for a long time, which requires high safety and needs to conform to the human bone structure. On the one hand, the ideal orthopedic implant material needs to have good biological properties such as biocompatibility, bioactivity and corrosion resistance, on the other hand, it needs to have good mechanical properties such as fatigue strength, mechanical stability, friction and wear performance. In recent years, new materials such as PEEK, degradable magnesium alloy and bioceramics have also appeared in clinical applications. The company has made corresponding layout for the research and development of new materials such as porous tantalum, magnesium alloy and PEEK, but there is still a certain gap compared with foreign giants. In the process of R&D, on the one hand, the company may face risks such as deviation in its own R&D direction, lagging R&D progress, and unsatisfactory R&D results, which may lead to an increase in R&D costs and time investment or even the suspension or failure of R&D projects; On the other hand, if the company’s R&D fails to achieve the expected material results and turn them into products, or the new materials cannot be effectively industrialized due to factors such as production technology and production cost, or the new materials cannot be successfully recognized by customers and markets, the company’s early R&D investment may not bring the company income or enhance its competitive advantage as expected, thus adversely affecting the company’s ability to continue to operate.

　　(4) Operational risks

　　(A) the risk of changes in sales model

　　The sales modes of the company’s main products include traditional distribution mode, two-vote distribution mode, distributor mode and direct sales mode. During the reporting period, the company’s sales model was mainly traditional distribution model. With the continuous expansion of the promotion scope of policies such as "two-vote system" and "purchasing with quantity", the revenue proportion of the company’s traditional distribution model will decrease year by year in the future. If the company can’t adapt to the changes of sales model in time and enhance the transformation ability of sales model, it will face the risk of blocked sales channels and customer loss.

　　(B) Market competition intensifies risks

　　The company’s main products are implantable orthopedic medical devices, and its end customers are medical institutions. For a long time, most of the domestic market share has been occupied by international brands such as Johnson & Johnson, Medtronic and Stryker. In recent years, with the technical progress and policy support, the trend of localization substitution is obvious.

　　However, the market share of domestic brands is still small, and domestic brands are facing fierce competition. The company must improve its product innovation and R&D strength according to market changes and industry development trends, so as to maintain its competitive advantage and develop steadily in the rapidly changing market environment. If the company fails to accurately grasp the development trend of the industry or correctly respond to the sudden changes in market competition in the future, it will face the risk of declining market share and product prices brought about by intensified market competition.

　　(C) the risk of declining market demand for implantable orthopedic medical devices

　　In recent years, with the acceleration of social aging in China, the number of patients with orthopedic diseases has accelerated, and the market scale of implantable orthopedic medical devices has also increased. In this context, during the reporting period, the company’s sales model increased year by year and maintained a high growth rate. If the disease spectrum or treatment methods change in the future, the clinical demand for implantable orthopedic devices will decrease or the medical insurance budget will decrease, which will lead to the decline of the market model of the company’s main products, which may adversely affect the company’s operation.

　　(D) Risk of income growth decline or fluctuation

　　From 2018 to 2021, the company’s operating income increased rapidly year by year, maintaining a good upward trend. Affected by the epidemic in 2020-2021, the growth rate of the company’s operating income declined. In the future, the company may fail to effectively expand sales channels, increase market share or promote R&D projects due to changes in macroeconomic environment, repeated epidemics, intensified product market competition and poor internal management of the company. The above situation may lead to a decline in the growth rate of the company’s operating income or a certain degree of fluctuation.

　　In September, 2021, the state organized the Joint Procurement Office of High-value Medical Consumables to publicize the results of this national procurement with quantity, and the terminal prices of the products to be selected by Chunli Medical and other selected manufacturers all dropped significantly. It is expected that the price reduction pressure will be further transmitted to the distribution price after the implementation of the procurement with quantity in the future. If the increase in the company’s sales volume cannot make up for the decline in the distribution price, the company may experience a decline in revenue and profits.

　　(E) Risk of supplier dependence

　　From 2018 to 2021, the company’s largest supplier accounted for a relatively high proportion of the total procurement in the current period. The specific products purchased by the company from CeramTecGmbH are ceramic ball heads, ceramic linings, etc. During the reporting period, the company increased the promotion of high-end products such as ceramic joint prostheses. In view of the high stability requirements of ceramic joint prostheses, the company chose CeramTecGmbH as the qualified supplier of ceramic parts of the company, and did not purchase similar products from other suppliers, so there was some supplier dependence. If we can’t reach an agreement with CeramTecGmbH on commercial terms in the future, or because of natural disasters, international trade disputes and other force majeure factors, CeramTecGmbH can no longer provide ceramic ball heads and ceramic linings to the company, which will adversely affect the company’s production and operation.

　　(VI) Lease risks of production and business premises

　　During the reporting period, part of the real estate used by the company for production and operation was acquired through leasing. If the lease cannot be renewed normally upon expiration, the rent is greatly increased during the lease renewal, or the lessor breaches the contract during the lease process, it may have a certain adverse impact on the normal production or operating costs of the company.

　　(seven) the risk of core materials relying on a single overseas supplier.

　　During the reporting period, the ceramic ball heads and ceramic linings used in the company’s ceramic joint prosthesis products were purchased from CeramTecGmbH. CeramTecGmbH is an advanced supplier of ceramic materials headquartered in Germany. Mainstream joint manufacturers at home and abroad, including Johnson & Johnson, Xerox, Stryker, Jiemai Bangmei, Aikang Medical, Chunli Medical and Weigao Orthopaedics, all purchase ceramic materials from the company. Due to international political and other force majeure factors, the supply of imported raw materials may be delayed, limited or the price may be raised. If the company can’t get enough raw material supply in time, the normal production and operation of the company may be adversely affected. At the same time, affected by international trade disputes, there is a risk that the purchase price will increase due to the increase of tariffs.

　　(VIII) external processing Risk

　　During the reporting period, the company’s spraying, basic machining, sterilization, surface treatment and other processes were mainly produced by outsourcing. If the company fails to effectively implement the outsourcing management measures, it may bring certain risks to product quality and delivery time; At the same time, if the outsourcing manufacturers fail to provide products with good quality and quantity according to the agreement, or violate the agreement, the company’s technical and commercial secrets will be leaked, which will have an adverse impact on the company’s production and operation.

　　(9) Risks not included in the procurement catalogue with quantity

　　In May 2019, the eighth meeting of the Central Committee for Deep Reform deliberated and adopted the Reform Plan for Managing High-value Medical Consumables. In July of the same year, the General Office of the State Council issued the Reform Plan for Managing High-value Medical Consumables, proposing: "For high-value medical consumables with large clinical consumption, high purchase amount, mature clinical use and produced by many enterprises, we should explore centralized procurement according to categories, encourage medical institutions to jointly carry out quantity negotiation procurement, and actively explore cross-provincial alliance procurement. Many provinces across the country have successively carried out pilot procurement of high-value consumables. On November 20th, 2020, the National Medical Insurance Bureau’s Medical Price and Bidding Guidance Center issued the Notice on Developing the Fast Data Collection and Price Monitoring of the Second Batch of Centralized Procurement of High-value Medical Consumables. The products involved in the second batch of centralized procurement include the following categories: artificial hip joint, artificial knee joint, defibrillator, occluder, orthopedic materials and stapler.

　　On April 1st, 2021, the Office of Joint Procurement of High-value Medical Consumables organized by the State issued the Notice on Information Collection of Some Orthopedic High-value Medical Consumables. On the basis of collecting the purchasing data of medical institutions in the early stage, in order to further understand the market situation of orthopedic high-value medical consumables, it is planned to carry out the information collection of orthopedic high-value medical consumables in batches. The first batch of high-value medical consumables such as artificial hip joint and artificial knee joint were collected.

　　On June 21st, 2021, the Office of Joint Procurement of High-value Consumables organized by the State issued the Announcement of National Centralized Procurement of Artificial Joints (No.1), and on August 23rd, 2021, it officially issued the Procurement Document of National Centralized Procurement of Artificial Joints, giving a comprehensive explanation on the product categories, procurement rules and bidding rules of this centralized procurement. The company won the bid for group A of ceramic-ceramic hip joint product system, group B of ceramic-polyethylene hip joint product system and alloy-polyethylene hip joint product system, but failed to win the bid for initial total knee replacement. The company’s inventory is relatively high, and it failed to replace the artificial total knee joint product system for the first time in the national procurement bidding with quantity. If the company can’t take corresponding remedial measures, the market demand will drop rapidly, and the company’s related products will face the risk of unsalable sales that are not included in the procurement catalogue with quantity.

　　(ten) the spine business scale is small, and the risk of losing the bid in the procurement with quantity.

　　At present, many provinces in China have implemented the purchasing policy of joint products, and Anhui Province has also introduced the purchasing of spine products. In the future, more provinces may introduce the purchasing of spine products. The overall scale of the company’s spine business is small, which has a certain impact on the company’s spine products to participate in the procurement with quantity, and there are certain disadvantages in the bidding competition, so investors should pay attention to the related risks.

　　(eleven) the uncertainty risk in the process of import substitution.

　　Although the overall gap between domestic orthopedic implantable medical device companies and international orthopedic implantable medical device giants is narrowing year by year, in the domestic and international markets, international giants still occupy the dominant position with strong technical strength, research and development capabilities, capital supply capabilities, brand influence and higher trust. With the gradual advancement of import substitution trend, both sides are also in a state of coexistence of competition and cooperation. In the process of import substitution, there is a certain gap between the company and international giants in terms of business scale, product technology, production capacity and brand building, and they will face certain challenges. In the future, the company will have certain uncertain risks in the process of import substitution.

　　(V) Financial risks

　　(A) the risk of a large balance of accounts receivable

　　From 2018 to 2021, the company’s accounts receivable balance continued to grow. If major adverse changes occur in the operating conditions of major customers and industry settlement methods, it may lead to overdue accounts receivable, bad debts or further extension of the accounts receivable recovery cycle, thus adversely affecting the company’s sustainable profitability.

　　(VI) Industry risks

　　The company is mainly engaged in the research and development, production and sales of implantable orthopedic medical devices, and its medical device industry must be fully supervised and managed by the National Development and Reform Commission, National Health Commission, National Medical Products Administration and other competent departments. Domestic enterprises engaged in research and development, manufacturing, management and use of medical devices should follow the regulations of medical device product classification management system, medical device product registration system, medical device production enterprise filing or licensing system, medical device management enterprise filing or licensing system, medical device management quality management standard, etc. The export sales of medical device products are also affected by the relevant policies of importing countries.

　　In recent years, policy changes at home and abroad have also caused multiple policy risks to the company, including:

　　(A) "quantity procurement" brought about by the risk of product terminal price decline

　　In July 2019, the General Office of the State Council issued the Notice on Printing and Distributing the Reform Plan for the Management of High-value Medical Consumables, exploring "procurement with quantity" in the field of high-value medical consumables. Up to now, Anhui, Zhejiang, Jiangsu, Fujian, Shandong and other provinces have issued and implemented the policy plan of "procurement with quantity" and implemented the bidding procedures involving joint products. Except for the company’s failure to win the bid for the "quantity procurement" of hip joints in Jiangsu Province in 2019, the "quantity procurement" of other provinces and related joint products won the bid. According to the current situation of winning the bid, the winning bid price of related products has mostly decreased to a certain extent compared with the price before "purchasing with quantity", which further led to a certain degree of decline in the ex-factory price of the company in some provinces.

　　In June, 2021, the National Joint Procurement Office of High-value Consumables issued the Announcement of National Centralized Procurement of Artificial Joints, Announcement of National Centralized Procurement of Artificial Joints (No.1), and in August, 2021, it officially issued the Procurement Document of National Centralized Procurement of Artificial Joints, and carried out the bidding work of national procurement of initial total hip replacement and initial total knee replacement. September 2021

　　In June, the state organized the Joint Procurement Office of High-value Medical Consumables to publicize the results of this national procurement with quantity. According to the public information, the average price of the hip joint terminal to be selected dropped by 80%, and the average price of the knee joint terminal dropped by 84%. The company successfully won the bid for "Ceramic-Ceramic Hip Joint Product System", "Ceramic-Polyethylene Hip Joint Product System" and "Alloy-Polyethylene Hip Joint Product System" at a relatively high price, but the price was significantly lower than that before the "quantity purchase". The company’s "knee joint product system" failed to win the bid because of its high quotation. The decline in the price of hip joint terminal and the failure to win the bid for knee joint will be transmitted to dealers and companies, and the subsequent distribution price of the company will also be reduced. If the increase in sales volume cannot make up for the decline in distribution price, the company may experience a decline in revenue and profit. In addition, if the company’s distribution price is too high, squeezing the dealer’s profit will affect the dealer’s willingness to cooperate, or returning the goods due to the termination of the dealer’s business with the company and negotiation, it may have a certain impact on the company’s profitability.

　　(B) The risk of knee joint products failing to win the bid for national procurement with quantity.

　　On September 14th, 2021, the State organized the Joint Procurement Office of High-value Medical Consumables to publicize the selected results of the national procurement of artificial joints, and the company failed to win the bid in the "knee joint product system". In 2021, Beijing Bestar Biotechnology Co., Ltd. (hereinafter referred to as "Bestar") obtained the "Record Certificate for Entrusted Production of Medical Devices" issued by Beijing Drug Administration, allowing our company to produce Bestar’s knee prosthesis as the trustee. Bethesda’s knee joint prosthesis won the bid in this collective procurement, and our company obtained the power of attorney from Bethesda (No.:BSD21-09- China -01-265), which authorized our company to sell its knee joint products in People’s Republic of China (PRC). Through the cooperation with Bestar, our company reduced the decline in profitability caused by the failure of our knee joint products to win the bid.

　　(C) Risk of changes in domestic and foreign industrial policies

　　The company is a medical device manufacturer, and its domestic sales revenue is the main source of its main business income. The domestic business development is strictly supervised by National Medical Products Administration and other competent departments. In 2018, the National Health and Family Planning Commission and other six ministries and commissions jointly issued the Notice on Consolidating and Breaking the Achievements of Supplementing Medicine with Medicine and Deepening the Comprehensive Reform of Public Hospitals, further clarifying the implementation of the "two-vote system" for the purchase and sale of high-value medical consumables. With the change of the sales model brought about by the two-vote system, the company is faced with changes in operating conditions such as longer receivable payment cycle and increased sales expenses corresponding to unit sales revenue. If the company fails to formulate effective countermeasures in time according to the changes in the "two-vote system" policy, it may have an impact on the sales and operation of its products.

　　In addition, policies such as medical insurance reimbursement and centralized procurement have been introduced in China, and policies such as DRGs and "one-vote system" have been actively explored. In 2021, eight ministries and commissions, including the National Medical Insurance Bureau and the National Health and Wellness Commission, jointly formulated the "Pilot Program for Deepening the Reform of Medical Service Price", with the goal of exploring and forming replicable and scalable medical service price reform experience through three to five years of pilot. In addition, the company is also actively exploring foreign markets, and the development of overseas business is strictly supervised by the competent authorities of relevant countries and regions. For example, the new version of the medical device regulation MDR passed by the European Union in March 2017, at this stage, some matters in the new MDR regulations have not yet been clearly defined, and there are certain risks of policy uncertainty.

　　In the future, the importance attached to the medical device industry at home and abroad will be further enhanced, and relevant regulations and policies will be issued in the aspects of industry standards, bidding, centralized procurement and circulation system. If the company can’t keep up with the development of industrial policies, study the requirements of new policies in advance, do a good job in coping with the New Deal, and continue to carry out technological innovation and product upgrading, the company may face the risk of falling product market prices, which in turn will lead to a decline in gross profit margin, which will adversely affect the company’s future profitability. The company will pay close attention to the trend of centralized purchasing policy, continuously strengthen production and management, enhance the company’s product innovation ability and comprehensive strength, strengthen market promotion, consolidate existing markets, develop new markets, and strive to increase market share.

　　(VII) Macro-environmental risks

　　In the future, the company may fail to effectively expand sales channels, increase market share or promote R&D projects due to changes in macroeconomic environment, repeated epidemics and intensified competition in the product market. The above situation may lead to a decline in the growth rate of the company’s operating income or a certain degree of fluctuation.

　　(8) Risks related to depositary receipts

　　(9) Other major risks.

　　

　　V. Main operations during the reporting period

　　The year 2021 is the year when China has built a well-off society in an all-round way, and it is also the first year of the 14 th Five-Year Plan. Standing at the historical intersection of the goal of "two hundred years", facing the global COVID-19 epidemic and the national joint "purchasing with quantity" environment, under the strong leadership of the board of directors, all employees of the company actively responded to the risks and challenges in operation, forged ahead, continued to reform, accelerated the research and development progress of new materials, new processes and new products, and actively expanded new pipelines to adapt to the new normal of epidemic and centralized procurement.

　　By December 31, 2021, the company achieved an operating income of 1,108,139,500 yuan in 2021, an increase of 18.18% year-on-year; The net profit attributable to shareholders of listed companies and the net profit attributable to shareholders of listed companies after deducting non-recurring gains and losses were 322,360,700 yuan and 307,693,000 yuan respectively, with year-on-year increases of 13.76% and 11.22% respectively.

　　The company’s main operating conditions are normal and its operating performance is stable. There have been no major changes in the company’s business model, the purchase scale and price of major raw materials, the production and sales scale and price of major products, the composition of major customers and suppliers, tax policies, etc., and there have been no other major events that may affect investors’ judgment.

　　VI. The Company’s Discussion and Analysis on the Company’s Future Development

　　(A) the company’s development strategy

　　Relying on the national industrial policy of encouraging domestic (or) instrument products, and relying on years of accumulated industry experience and technical advantages, the company is committed to developing and producing joint prostheses, spinal implants and other products with excellent performance, and strives to become a world-class comprehensive medical orthopedic instrument manufacturer as soon as possible.

　　(3) Business plan

　　1, the rational use of capital market financing tools to enhance the company’s financing ability.

　　With the help of the capital market platform, the company will broaden the channels of capital operation, enhance the visibility of enterprises, enhance the ability to resist risks, enhance competitiveness and industrial integration, and rationally use the financing tools in the capital market to enhance the company’s financing ability, which is conducive to further promoting the company’s business development and helping the company’s long-term sustainable development in the future.

　　2, continuous talent introduction and training, to create a compound professional talent echelon.

　　The company will continue to implement the people-oriented human resources strategy, introduce and effectively cultivate compound talents on the basis of the existing talent team, cultivate cross-knowledge structures in marketing and academic promotion, research and development, production and comprehensive management, and establish a marketing system with flexible organization and project management as the leading direction to meet the needs of the rapid development of the industry and the company. The company will further establish a standardized and professional training system, strengthen employee on-the-job training and follow-up education and training, fully mobilize the enthusiasm and creativity of employees, give full play to their potential, and actively cultivate their expertise to achieve sustained and healthy development with the company.

　　3. Improve the construction of R&D platform and effectively promote the overall layout of products.

　　Based on the existing R&D capabilities, the company plans to build a multi-functional R&D platform that can meet the company’s long-term R&D requirements, and improve the company’s independent R&D capabilities and new product R&D efficiency. In the future, after the R&D center project of the company is completed and put into use, the company will make full use of advanced hardware conditions, rationally use R&D funds to effectively invest in the research and development of new products, improve the R&D transformation ability, further enrich and optimize the company’s product pipeline, and better provide orthopedic implanted medical devices with high quality and strong applicability for patients with orthopedic diseases.

　　4. Improve the construction of marketing network.

　　In the future, the company will further improve its marketing network, meet the growing demand of the downstream market and consolidate and expand its market share in combination with the expansion of its production capacity.

　　After the completion of the new marketing network project, the coverage and radiation level of the company’s marketing network will be further strengthened. The construction of marketing training center will provide systematic support for the clinical promotion and doctor training of the company’s products, and promote the brand promotion of the company in an all-round way and enhance the brand image of the company. The rapid expansion of marketing and distribution outlets will help the company quickly respond to the needs of terminal medical institutions and provide matching products for personalized orthopedic surgery in time. The marketing network information system, the newspaper station system and the customer management system will further strengthen the company’s management ability to customers, distributors and terminal hospitals and improve the level of information management.

Manchester United suffered a bloody massacre at Crystal Palace, setting a new record of humiliation in team history, and the coach’s tactics caused public outrage.

In the 36th round of the Premier League that ended last night, Manchester United suffered a 4-0 humiliation at Crystal Palace. This fiasco not only made the Red Devils rank eighth in the Premier League this season, but also set a new record for the team’s 13 defeats in a single season. What is even more unacceptable to fans and the media is that this is the first time that Manchester United has been double-killed by Crystal Palace in the Premier League. This achievement is undoubtedly a great irony to Manchester United, a traditional Premier League giant.

During the game, Manchester United’s performance was a mess. In the first half, Manchester United’s defense was full of loopholes, allowing opponents to easily take a two-goal lead. In the second half, although casemiro scored a goal, it was ineffective because of offside, and Manchester United’s attack was even more disorganized. He was scored two more goals by Crystal Palace and finally lost 0-4.

The tactical arrangement and personnel arrangement of Manchester United coach in this game have been widely questioned. Before the game, some media and fans worried that Manchester United’s midfield pressure would lead to an empty defense. As a result, this concern was verified in the game. Although casemiro is active, but he has limited individual combat ability, he can’t effectively intercept the opponent’s attack after referring to the position of the lower back, which makes Manchester United’s defense even more stretched.

What is even more unacceptable is that Manchester United’s attack has no routine in the game. Garnacho, Anthony and Hoyle, the trio of strikers, lack tacit understanding, and fight for each other, which leads to the low attack efficiency of Manchester United. This kind of performance is undoubtedly a great doubt about the coach’s tactical arrangement ability.

Dong Fangzhuo, an old Manchester United player, also commented on the game after the game, bluntly criticizing the team’s performance and the coach’s tactical arrangement. He said that Manchester United’s current problem is not only injuries, but also the mismatch between the tactical system and the characteristics of players. He called on the team to re-examine their tactics and find the most suitable way to play.

This fiasco is undoubtedly a heavy blow to Manchester United. At the end of the upcoming season, Manchester United needs to adjust its state as soon as possible and find a solution to the problem. Otherwise, such a performance will not only disappoint the fans, but also put this traditional Premier League giant’s position in the league in jeopardy.

Special feature of 1905 film network The suspense comedy film was released on May 1st, 2024, directed by and starring,,,,,.

The film tells the story that four strangers share the stolen goods in the backstage warehouse of the theater, but they are accidentally involved in a murder case. A hot pot in YOLO rolls with endless suspense, and greed and deception lead to a series of reversals. Finally, the special identity of the four people gradually surfaced, and the mysterious truth is also coming to the fore.

What’s so particular about the hot pot in Jiugongge in the movie? The studio of ""moved to a real hot pot! Director Sheng Ding and the host talked about this hot pot movie on the spot. Director Sheng Ding thinks that the most important thing is "fire", for example, in the movie "Nothing can’t be solved in a hot pot" played by Yu Qian, who is the director of the hot pot, and director Sheng Ding thinks it is the middle of the nine squares — — "fire"

The other eight squares in Jiugongge, such as Mo Ji, Fu Director, Fa Cai and 70,000 in the movie, are small fire, medium fire and fierce fire, which are constantly changing according to the plot.

At this point, Director Sheng Ding humorously appealed to the audience to enter the cinema: "If there is another fire, it will be the fire of the audience. I hope that the audience will help more at this time, so that our hot pot fire will be stronger and the taste will be stronger! "

Then, in this issue of "Today’s Film Review", Sheng Ding, the director, will be a guest to talk about the hit film "Nothing can’t be solved by a hot pot" directed by him.

One of the highlights of the film is the red hair and performance of actor Yang Mi. According to the director, Yang Mi didn’t catch fire in the first third of the film, and everyone would think that she was an "incombustible" with a simple and ignorant role, but she was paving the way for the subsequent contrast.

By the time of Yang Mi’s cross-dressing, Yang Mi suddenly became a red head. When she sat on the table eating hot pot, Yang Mi in the camera became a completely different person.

Regarding Yang Mi’s performance, Director Sheng Ding said: "From the aspects of eyes, voice and voice expression, the status of the characters has changed, and the gas field has spread out. When I watched it on the monitor, I felt that the characters basically became." Therefore, Yang Mi’s role as a chicken is compared to "fierce fire".

Besides Yang Mi’s careful polishing of the characters, Yu Qian’s analysis of the characters is particularly profound. Director Sheng Ding revealed that Yu Qian’s character Jiubing had originally set up a scene in which Yu Ailei wanted to smoke and Yu Qian refused to let him. It turns out that this scene has no comedy effect. Now they have designed a bridge that blows, blows out, opens again and blows out again, and interprets a key scene with silent performance.

And after the complicated plot, the relationship between them is closer, which continues the previous smoking behavior, with very delicate connotation and rich emotional changes.

In addition to the dedication of the actors, the popularity of the May Day schedule is inseparable from the active participation of movie audiences. If a movie wants to be popular, it depends on the audience’s choice. Faced with so many audiences’ comments, Director Sheng Ding chose to face directly in the program. What would he say?

"It would be better if the duration was controlled at about one and a half hours.The large-scale script killing is very dramatic, and the actors perform delicately. "

Director Sheng Ding said that when he wrote the script, he planned to film 95 scenes in about two hours, and now the whole film really exceeds four minutes. It takes two hours to tell this story, and each scene is more than one minute. If you subtract half an hour, you will lose about 20 scenes, so you will lose it.allowmanyPlot. So it won’t fit in an hour and a half.

"Mahjong, hot pot, and opera elements have nothing to do with each other, but in the atmosphere where movie crime plots and joy coexist, everything is nothing."

In the movie, the distance between roles is relatively close, so it is impossible to do complicated scheduling actions. It also includes a lot of dialogue and inner activities of actors. Director Sheng Ding thinks that in such a performance environment, the characters need the fulcrum of behavior.

Mahjong, hot pot and Sichuan Opera can be regarded as elements that reflect the fireworks in Sichuan and Chongqing, and they all have symbolic meanings. For example, mahjong is used in the first part of the film when telling the plan. This feeling of planning and fighting suggests the psychological activities of the characters.

And when "Guan Yu" broke in, Director Fu took a "seventy-two-change" the Monkey King Facebook, but was subdued by Guan Yu. In fact, the mask itself has its own meaning and information, and the Monkey King, who is omnipotent, can’t "play broadsword" in front of Guan Gong.

As the "chef" of the movie "Nothing can’t be solved with a hot pot", director Sheng Ding once heard many voices of doubt: "Director Sheng Ding is an action film director with average storytelling ability". For Sheng Ding, these comments can’t discourage him. Ambitious, he hopes to make the audience feel that he is also a good storyteller through his works.

I remember at the premiere, the director commented on Sheng Ding: "You made a literary drama into a martial arts drama." Sheng Ding also agreed after listening. "This is what I want to do."

Referring to the behind-the-scenes story, Sheng Ding, in order to make Wen Nengwu, brought the tension of rhythm and the smoothness of perception through audio-visual language and editing techniques, and experienced difficult choices and choices on the editing stage. Finally, this version presented to you is the seventeenth version.

Before the film was released, Sheng Ding also publicized the film for many times in public. Now the film "has seen the light of day", which needs the audience to test not only the "Meet the Works" that Yang Mi promised to the audience at the beginning of the year, but also an answer sheet of director Sheng Ding about "telling a good story".

During the May Day holiday, I hope that this film "Nothing Can’t be Solved in a Hot Pot" can help the audience to relieve the pressure of work and life, enter suspense by comedy, take a trip to Sichuan and Chongqing through movies, and experience the open-minded psychology of "carrying the past and solving it" in the movie.

　　

　　"Should I get my frozen money back?" One day in August last year, the first sentence of a Chengdu aunt who walked into the police station did not want to lead to a series of transnational communication fraud cases.

　　The lady who lives in Wuhou District was cheated by a Taiwan Province-born "gold master" and set up a communication fraud den in India for nearly 9.6 million yuan at one time, which alarmed the Ministry of Public Security.

　　After more than half a year’s hard investigation and international police cooperation, the Chengdu police, with the strong support and guidance of the Ministry of Public Security and the Sichuan Provincial Public Security Department, have arrested 51 suspects of den communication fraud, including 4 Taiwan Province nationals. This is the first time that Chengdu has destroyed transnational communication fraud gangs.

　　On the afternoon of the 25th, the Chengdu Public Security Bureau held a briefing on this, revealing in detail the "8? Many details of the 25 "mega-transnational communication fraud case.

　　

　　

　　Encountered a trap, Chengdu aunt was cheated for 9.6 million at a time.

　　On August 25 last year, Chengdu aunt Wang Dali (a pseudonym) walked into the police station of South Station in Wuhou District to report the case. When she saw the police, Wang Dali’s first sentence sounded strange: "Should you give me back the money you frozen?" The police inquired in detail and found that the aunt who came to report the case in front of her was likely to encounter communication fraud. The other party was pretending to be "frozen" by the public security personnel and actually transferred her money.

　　Wang Dali still doesn’t believe several times that she may be cheated. When she realized what had happened, the police almost swallowed a cold sweat when she revealed the situation again: Wang Dali said that all the 9.596 million yuan in her account was gone, and as early as August 17 to 19, she was transferred in batches according to the instructions of a "prosecutor" of the "highest inspection".

　　The police station immediately reported the case, and the intelligence department of the Criminal Investigation Bureau of Chengdu Public Security Bureau quickly intervened. The single case was defrauded of 9.6 million, and the amount involved was huge, which is rare in China. Chengdu Municipal Bureau also reported the case to Sichuan Provincial Public Security Department and Ministry of Public Security, and received guidance and help from the two levels of public security departments.

　　

　　Taiwan Province’s "golden master" India built a fraud den.

　　The investigators of the task force have done a lot of investigation work through technical means. I learned that Wang Dali was cheated by a transnational communication fraud den with clear division of labor. By inquiring about the phone call to Wang Dali, the den is not in China. What is the structure of this den and how to divide the work of fraud are not clear for the time being.

　　The task force first found a breakthrough point, and determined that a man from Santai County, Mianyang should be one of the suspects through the comparison between the abnormal personal account and the entry and exit records. Through this one person to sort out social relations, from one person to three people, I slowly found out the structure of this den from the periphery.

　　

　　

　　

　　Fraudsmen’s dens in India

　　Make sure that it was set up and managed by Taiwan Province people, and it was located in a farmhouse in Gujarat. After the case was reported to the Ministry of Public Security, it became a "double-linked" case supervised by the Ministry of Public Security and the Supreme Procuratorate.

　　

　　Sichuan Public Security’s First Cross-border Police Cooperation

　　Under the leadership and command of Sichuan Provincial Public Security Bureau, Chengdu Municipal Bureau reported to the Ministry of Public Security on its own initiative and proposed to go abroad to crack down on dens. The Ministry of Public Security strongly supported this, and connected with the Indian Embassy in China through the Bureau of International Police Cooperation. At the same time, the task force investigated and controlled various aspects of the den, such as capital exchanges and communication exchanges, and mastered more key information.

　　In January this year, under the leadership of the Ministry of Public Security, a joint working group composed of the Sichuan Provincial Public Security Department, the Chengdu Public Security Bureau, the Intermediate People’s Court and the Procuratorate rushed to India. This was the first time that the Sichuan Public Security Department went abroad to carry out police work. After nine days in India, it laid the foundation for more targeted investigation, control and arrest after returning home.

　　

　　Telephone fraud has a standard "script"

　　After technical control and basic investigation abroad, we found out the characteristics of this fraud den that defrauded Ms. Wang of Chengdu of 9.6 million yuan: the number of operators is about 30 to 50, except for a few "second-line" and "third-line" operators who are from Taiwan Province, all the "first-line" operators are from Chinese mainland, and most of them are from Sichuan.

　　At the top of the den is a Taiwan Province "gold master", who paid to set up the den. This gold master does not go to India, but only pays. It is his fellow countryman in Taiwan Province, nicknamed "Monkey Brother", who is responsible for recruiting personnel and overall management of the Indian den. Most of the recruited operators are "experienced personnel". Later, it was learned through trial that a considerable number of operators had also worked in transnational communication fraud dens in Malaysia, the Philippines and other countries.

　　Taiwan Province financial owners have hired special personnel to train telephone operators. The main mode is to pretend to be the "Taiwan Province Department" of fraud by the public security organs. What role should the first, second and third line operators play and what to say in which process? They have a standard "script book", and all fraud is carried out in strict accordance with this "script book" routine.

　　

　　Detailed restoration of Chengdu aunt was cheated

　　In August last year, the first phone call pretending to be a credit card center of a bank in Wuhan was made to Wang Dali’s mobile phone from this rural house in India.

　　The first appearance is the "first-line" operator, which is the rough work of casting a net. He asked if he had a credit card from a bank in Wuhan. Most people will hang up, but Wang Dali answered and told them no. The "first line" said that we are a credit card center, and the system shows that we have used your name to do the card, and there are more than 10,000 yuan in arrears.

　　Then, the "first line" saw that she was nervous and asked her to report the case immediately. "We have a special line with the police. How about transferring it to you directly?" Aunt Wang immediately agreed to transfer to Wuhan "Jiang ‘an District Public Security Bureau".

　　The "second line" appeared, which is a much higher-tech link. His role is a policeman and he needs "skills" very much.

　　The "second line" tone was very serious and asked Wang what happened. Wang replied that his bank credit card was fraudulently used. At this time, the "second line" showed the majestic momentum of the police. According to the routine of "speaking the script", he said to Wang: Have you done it? You should tell the truth. You are not as simple as being falsely used now. We have a "Li Gang fraud case" here, and you are a suspect in the investigation.

　　At this time, another person with a clear division of labor immediately set out to make a "highest wanted notice" according to Wang Dali’s detailed personal information, and put it on their specially made fake webpage as soon as possible.

　　Aunt Wang is getting more and more afraid. "If you can’t prove yourself, we will take compulsory measures. You can either cooperate on the phone or our task force will come to your home in Chengdu to find you." Wang quickly promised to cooperate by phone.

　　The "second line" asked her how much money she had and what cards she had on it. "You have to tell the truth, if there is personal property hiding, we will freeze your funds." She told me how much money each of her cards had.

　　At this time, the "second line" seriously instructed her to transfer the money from each bank card to one card, realizing the step of putting the money together in a pile. And let her open an online bank and run a "K treasure". Tell her it’s troublesome and need to contact the "highest leaf inspection prosecutor".

　　The "third line" with the highest technical content appeared.

　　The "third line" asked her to go to the computer, gave her a website and told her that there was "big trouble" in the current situation. Wang Dali’s wanted order for this fake webpage specially made by them has been displayed impressively. She believed it after reading it, and at this time she has completely obeyed any instructions from the other party.

　　Let her log in to the online bank, and the "third line" does not say transfer money. There is the most crucial step. In other cases of fraud, if the victim is in a hotel room (being asked to avoid family and friends), they will be asked to cover the KBao display screen with a towel, because the small display screen will show that the money is being transferred, and various reasons will be found for the victim to cover it. For Aunt Wang, the "Third Line" asked her to cover the display screen with her hand, saying that it was "fingerprint verification", and then remotely controlled Wang’s computer through another computer-savvy accomplice, so that she kept pressing the operation on "KBao".

　　In such a final stage, Aunt Wang finally failed to hold on. Aunt Wang and her wife usually lived alone, their children were not around, and their wife was not at home at the time of the incident. In this way, in three days, more than 3 million were transferred in batches on the first day, more than 1 million on the second day and more than 5 million on the third day.

　　

　　Sanya celebrates its annual meeting with one pot.

　　By the time Aunt Wang reported the case, her money had already been transferred away. After thorough investigation, the police found that this fraud gang headed by Taiwan Province people has a very strict division of labor, including the transfer of funds. The 9.6 million yuan cheated by Wang was quickly dispersed and transferred to five-level accounts, and some of them entered the third-party payment platform. The most difficult thing is that fraudulent funds are mixed into different accounts. If metaphorically speaking, it is like pouring a lot of buckets of water into a pool. There are fraudulent money and normal business money in it, which brings great difficulties to the investigation work.

　　Knowing that she was cheated, Aunt Wang almost collapsed and was saddened.

　　Through a lot of technical investigation, on February 15th during the Chinese New Year this year, a breakthrough clue was obtained: two important Taiwan Province suspects from the den entered Sanya! Under the command of the Ministry of Public Security and the Provincial Public Security Department, the task force rushed to Sanya to directly arrest.

　　In order to prevent spooking the snake, the police arrested him in plain clothes. After arriving at the scene, the police found that some suspects were out of the activity site, and the situation was much more complicated than expected. The police had to wait near the hotel. According to the on-site police, there were 11 men, women and children at the scene. After careful preparation, with the cooperation of Sanya police, 11 people were arrested in a hotel on February 16.

　　The surprise trial found that it was precisely because of defrauding many victims, including Aunt Wang, that the gang took advantage of the Chinese New Year to go to Sanya for a holiday and hold an annual celebration meeting. Among the arrested people, there were three Taiwan Province nationals, including the second-in-command of the den, namely "Monkey Brother", Jin Rui, who has been managing for a long time and has a position equivalent to the general manager, and a "second-line" operator. This is the first time that Taiwan Province nationals have been caught in communication fraud in Sichuan Province.

　　

　　The operator’s commission is as high as 800 thousand yuan

　　According to the police, all the suspects recruited into the fraud dens have had many fraud experiences. After these people were recruited, a special person collected their documents and unified them to the travel agency that handled the visas for these people, which lasted for 90 days. After that, these people took the air tickets provided by the financier and transferred from Hong Kong to India. After the plane landed, these people were taken to the dens by Indian locals.

　　"According to our trial, the following operators don’t know where they are in India, only know that they are in India, and they can’t tell the specific location. After they arrived in India, they could only move in the prescribed places, and their phone cards and documents were taken away. " The police told reporters.

　　Through the first night’s trial, the Chengdu Public Security Bureau is ready to strike while the iron is hot and arrest the suspects in Sichuan Province. At that time, it coincided with the Chinese New Year holiday, and almost all the suspects went home for the Spring Festival. The Chengdu Public Security Bureau arrested 15 people in one fell swoop.

　　According to the suspect, in 8? In the case of communication fraud, just being in charge of the third-line work-playing the suspect of the Supreme People’s Procuratorate prosecutor, in this single case, he got a commission of more than 800,000 yuan. The other two "first-line" and "second-line" also received hundreds of thousands of yuan.

　　Xiong Jian, the squadron leader of the Criminal Police Brigade of Wuhou District Public Security Bureau, one of the members of the task force, revealed that so far, "8? 25 "mega-transnational communication fraud case series and cracked 136 cases in the whole province, including 107 cases in Chengdu, and many cases from other provinces, involving more than 30 million yuan. At present, 51 suspects have been arrested, including 4 suspects from Taiwan Province and 47 suspects from mainland China. Of the 51 suspects detained, 39 have been arrested, 8 have been released on bail and 4 have been prosecuted. The case is still under further investigation.

　　Cover journalist Li Fengchun Intern Zhong Xiaolu According to Chengdu Public Security Bureau

　　interlinkage

　　Chengdu police cracked down on new crimes in communication networks and destroyed more than 30 dens.

　　The reporter learned from Chengdu Public Security Bureau that during the period from December 21st last year to July 20th this year, Chengdu police accepted 2,567 cases of communication fraud, down by 28.4% year-on-year, and established 2,348 cases of communication fraud, down by 30.7% year-on-year. The amount of communication fraud losses was 68.92 million yuan, 392 cases of communication fraud were cracked, 250 suspects of communication fraud were arrested and more than 30 illegal criminal dens were destroyed.

The 15th China International Aviation and Aerospace Exhibition is just around the corner, and well-known aviation enterprises, top pilots and air show teams from all over the world gather in Zhuhai. Sergei Bogdahn, a test pilot from Russia, also arrived at the Zhuhai Air Show with the Russian fifth-generation stealth fighter Su -57 numbered 054.

After completing the transition, Hero of the Russian Federation became interested in Dongfeng, the official designated vehicle for this China Air Show, and strongly demanded a test drive at the scene. After circling the field for many times, it was even more difficult to hide his excitement. He held up the model of Dongfeng 917 and called "Brave Man, Hula"!

The fifth generation Russian stealth fighter Su -57 made its debut in China, and the heroic test pilot Sergei Bogdahn, who is over 60 years old and has legendary experience, took on the heavy responsibility of transition and flight performance.

Since graduating from aviation school, Sergei Bogdahn has flown more than 7,000 hours, and mastered the flying skills of more than 50 types and improved aircraft in his career. As the chief test pilot of the fifth-generation fighter of Su -57, he used to fly Su -25UTG and Su -33 aircraft on the "Kuznetsov" aircraft carrier for the test flight of complex subjects. In 2000, Bogdahn was awarded the Medal of Courage, and in 2011, he was awarded the title of Hero of the Russian Federation and the Russian Gold Medal.

As a soldier who has served in Russia for many years, Sergei Bogdahn took a fancy to the official designated car-Dongfeng Warrior 917, which obviously has China’s military origin, at Zhuhai Air Show. From the early EQ240 to the birth of China’s three-generation high-mobility military off-road vehicle "Warrior", Dongfeng Motor has accumulated rich technology and experience in the field of military off-road vehicles.

As a luxury electric off-road vehicle that inherits the profound military gene of Dongfeng Warrior brand, Dongfeng Warrior 917 is the only vehicle in China that has passed the "National Military Standard" (GJB) durability test by drawing lessons from the aesthetic design of military vehicles and adopting a large number of off-road technologies. Dongfeng Warrior 917 put a large number of military-grade technologies on civilian vehicles, such as integrated internal high-pressure longitudinal beam, front and rear double wishbone independent suspension, far-infrared night vision technology, etc. No matter the design concept of "heroic soul" or the powerful off-road performance of global access, Sergei Bogdahn was very surprised and his experience was directly filled.

The 15th China Aviation and Aerospace Exhibition will officially open on November 12th, 2024. The same model "China’s first luxury electric off-road vehicle"-Dongfeng Warrior 917, which is especially loved by Sergei Bogdahn, the chief test pilot of Su -57, will also bring extraordinary new oriental luxury electric off-road experience to Chinese and foreign guests.

Many people will confuse Lanyun with its big brother, thinking that it is a high-performance sports version. In fact, apart from the difference in price, they are actually different in appearance size, interior and power system. This article will introduce this car to you.

First of all, the square shape of the appearance has not changed much, and the proportion of the air intake grille on the front face is not too large. The honeycomb blackening treatment makes it more domineering. The light groups on both sides, you are not 142 independent light sources, and realize a variety of different lighting methods. If you want to install this headlight, it will cost 1.52 million yuan.

The side can feel its tall and powerful, and its waistline is also very simple and capable. This car adopts the design of suspended roof, which enhances the overall aesthetic feeling, and the front is also equipped with carbon fiber decorative cooling holes, which shows its sports performance.

The black lower fender on the rear of the car opens the visual width of the whole rear of the car, and then the exhaust design and chrome-plated tail throat on both sides make it more exquisite. Then the logo of sport at the rear of the car immediately shows the identity of its own sports version.

In terms of interior decoration, the sense of luxury and the inclined plane design with a large angle are very aesthetic. In terms of materials, all the places within reach are wrapped in pure leather, and the touch is very delicate. Then, of course, the two large screens in the central control area are the most scientific in the overall interior. The quality of 10-inch and 10.2-inch LCD screens is also very clear, and the mediation of touch control is also very sensitive and responsive. In terms of seats, the carrying, filling and wrapping are very good, and you feel very safe sitting here.

The official acceleration of 100 kilometers is 6.6 seconds, compared with the official data of 6.1 seconds. Although the performance is good, the transportation will still be slightly inferior. Whether you are cruising in the countryside or in the city, it can easily cope with it, fully embodying the rough characteristics of American style.

The car map and configuration in this article are provided by Yaxun () International Freight Forwarding Co., Ltd. If there are any mistakes, please leave a message in the comments!

No. author provides articles.

Promote the infrastructure construction of vehicle networking and guide the coordinated development of industrial innovation … At the beginning of the new year, the Decision of Jiangsu Provincial People’s Congress Standing Committee on Promoting the Development of Vehicle Networking and Intelligent Networked Vehicles was officially implemented. Previously, Wuxi and Suzhou began to implement policies to promote the development of the Internet of Vehicles in March and December 2023, respectively. In recent years, Jiangsu has vigorously developed the car networking and intelligent networked automobile industry, and continuously expanded the scope of road testing and demonstration applications. At present, what is the development of the car networking and intelligent networked automobile industry in the province? How far is it from commercialization?

The ecosystem is constantly improving,

"Internet of Vehicles" and "Networked Vehicles" blossomed more.

AR real-time monitoring of road congestion, pedestrians crossing the road monitoring and early warning, unmanned automatic parking … Entering Wuxi car networking town, smart car networking application scenarios are frequently seen. In Xishan District, Wuxi City, where the town is located, a self-driving minibus with cool appearance shuttles flexibly through the traffic at an average speed of 35-40 kilometers per hour every day.

Zhen Hongbo, general manager of Wuxi Car Networking Town, Nanshan, China, introduced that lidar and cameras all over the self-driving minibus help the vehicle to look around in a 360-degree view. Up to now, the self-driving minibus has accumulated a mileage of 458,300 kilometers on three routes in the region, and has connected 48,800 passengers.

Smart cars ride on the "smart road". Every day, there are all kinds of smart driving vehicles running and testing here in Tiancheng Road, the new south of Suzhou High-speed Railway, including L4-class self-driving unmanned minibus, small unmanned delivery vehicle and self-cleaning unmanned sanitation vehicle … At present, Suzhou High-speed Railway New Town has built 250 kilometers of intelligent networked test roads, and deployed over 1,100 sets of side equipment, opening up intelligent networked vehicle road test and demonstration applications all over the world.

"Jiangsu’s testing and application of intelligent networked vehicles has already taken the lead in the country." Dai Yifan, director of Jiangsu Intelligent Networked Vehicle Innovation Center, introduced that a number of demonstration application scenarios of intelligent networked vehicles, such as taxis, buses and special work vehicles, have landed in Nanjing, Suzhou, Wuxi and other cities and achieved large-scale commercial applications.

Outside the car road, there is no shortage of cloud links. In September, 2023, the shared information screen at the rear of Changshu No.135 bus changed quietly, and the application scenes such as traffic light timing, front image information and road guidance were displayed in real time when the vehicle was driving. Steven Yang, chairman of Jiangsu Tianan Zhilian Technology Co., Ltd. told the reporter that the V2X vehicle-road collaborative vehicle networking system developed by the company was installed on the bus. "With the help of roadside cameras, radars, laser integrated machines and other sensing devices, vehicles can accurately identify pedestrians and non-motor vehicles around them, and prevent’ ghost probe’ traffic accidents."

Qi Yong, director of the Jiangsu Intelligent Transportation and Vehicle Networking Engineering Research Center and a professor at Nanjing University of Science and Technology, said that the intelligent vehicle networking industry includes not only the intellectualization and networking of automobiles themselves, but also the intellectualization and informationization of infrastructure such as roads. "At this stage, the development of the intelligent vehicle networking industry needs to be promoted in a way of’ vehicle-road coordination’, and it is necessary to simultaneously coordinate’ smart cars’,’ smart roads’ and’ powerful clouds’ to achieve three goals.

In Jiangsu, the whole industrial chain ecosystem covering "cars", "roads" and "clouds" is constantly improving. According to statistics, in 2022, there were more than 700 intelligent networked cars and car networking enterprises in the province, with an operating income of more than 140 billion yuan, forming a relatively complete industrial chain covering intelligent vehicles and parts and information interaction systems. The development level of high-performance computing chips, autonomous driving software algorithms, testing and verification, and car networking facilities and equipment is leading the country. At the same time, the province has built the most extensive car networking infrastructure in China, achieving large-scale coverage in the whole urban area of Wuxi and key urban areas such as Nanjing, Suzhou and Changzhou.

"Smart car" is the core element of the industry.

Bicycle intelligence still lacks revolutionary breakthrough

The industrial system of intelligent car networking is generally composed of intelligent networked cars and car networking. At present, the construction of related industrial systems can be regarded as the organic integration of the technology markets of vehicles, roads and clouds.

Report to the 20th CPC National Congress of the Communist Party of China proposed to promote the development of strategic emerging industries integration clusters. Qi Yong said that this has provided a fundamental basis for the construction of the intelligent vehicle networking industry system. "It is a typical integrated strategic emerging industrial cluster to organically graft sensors, computers, big data and artificial intelligence, promote the construction of major projects and characteristic industrial parks, and create an innovative cluster of intelligent vehicle networking industries."

"Because vehicle companies are directly oriented to consumers, the technology market of cars is the largest, and its proportion in the whole industrial system even exceeds 50%." Dai Yifan believes that even the key core technologies involved in intelligent networked vehicles account for the largest proportion among cars, roads and clouds. "Although the coordinated promotion of’ road’ and’ cloud’ is essential, it includes technologies in the fields of driverless, sensors, controllers, chips, algorithms, etc., and technical research for bicycle intelligence is at a more core position in the construction of the entire industrial system."

Focusing on bicycle intelligence, in recent years, various technical research and testing have been intensively promoted in many places in the province. However, the intelligent networked vehicle technology is mature and there is still a long way to go. "It may take 8-10 years to really develop into the driverless stage and get consumer recognition." Dai Yifan said.

What’s the difficulty? According to Xiang Junping, deputy general manager of China Ship Lianyungang Jerry Electronics Co., Ltd., strictly speaking, as long as the vehicle is not equipped with OBU before leaving the factory and cannot be interconnected with RSU on the road, it cannot be called "intelligent networked vehicle".

"In fact, because the bicycle intelligent technology is not mature enough and the road side is not intelligent enough, there are not many scenes for the interaction between cars and roads. At present, the cost performance of installing in-vehicle units is relatively low, which leads to the weak willingness of car companies and the low acceptance of consumers." Xiang Junping revealed that the cost of a vehicle-mounted unit device generally needs several thousand yuan. If it is installed before leaving the factory, it will undoubtedly increase the cost of the vehicle and push up the price of the whole vehicle. However, the automobile market involving bicycle intelligence is a completely competitive market, and the technical iteration is mainly driven by the enterprise R&D department. The limited power of car companies makes it difficult to mass-produce vehicles, although there are objectively test and application vehicles; Although there are technological upgrades, there are few revolutionary breakthroughs.

Change "car watching lights" to "car watching lights",

"Smart Road" urgently needs more traffic data.

In Jiang Xinzhou, the unmanned minibus sightseeing bus has been put into use. In the test section, the vehicle will keep driving at a speed of 30 kilometers per hour, and automatically follow the car, turn, wait for traffic lights and pass the intersection according to real-time traffic information. All of this is based on the intelligent transformation of infrastructure in related roads.

It is very important to guide "smart cars" with "smart roads". "When the bicycle intelligence matures, it will also encounter the’ ceiling’, and there will still be a’ perceived blind spot’ in the vehicle sensor." Ben Wei, deputy general manager of Nanjing Rice Network Technology Research Institute Co., Ltd. told reporters that installing roadside unit facilities on roads can form interconnection with vehicle-mounted units, thus reducing safety hazards and improving travel efficiency.

In fact, the "smart road" is not only to provide technical assistance for "smart cars", but also to build an insurance to promote the development of the entire industrial system.

What should the "road of wisdom" look like in the future? "In the short term, we should also focus on empowering the existing traffic management model. When most vehicles realize intelligent networking in the future, the traffic control method can be profoundly changed. " For example, Ben Wei said, like traffic lights, the ultimate expectation of road intelligence is to change from "watching the lights by cars" to "watching the cars by lights". "By increasing the means of perception on the road, dynamically adjusting the release time of intersections is equivalent to arranging a highly intelligent intersection traffic commander."

However, due to the lack of intelligence and the low road coverage of intelligent network connection, except for some sections of the relevant pilot area and pilot area, the current "car watching lights" is still the mainstream, and the phenomenon of "empty waiting" and "empty flying" at intersections is still common.

"At the moment, we are gradually getting through the information of car sections and road sections." Zhen Hongbo said that when the vehicle drives to Xidong Business District and Xishan District, where roadside equipment has been rebuilt, it will take a few seconds to hear the navigation warning red light. Once this area is opened, you will not experience the "green wave" reminder.

In the interview, some insiders mentioned that the cost of roadside reconstruction is very high, and the industry is in its infancy, many standards are not unified, and many products still have the possibility of continuous iteration, which also delays the progress of road intelligent reconstruction.

Technology is one aspect, and a lot of traffic data is needed to build a networked road. The person in charge of the relevant enterprise told the reporter that the right to use traffic data belongs to the traffic control department and cannot be opened to enterprises providing technology.

Ben Wei said that in fact, car companies also have demands for purchasing data. "Many’ new forces to build cars’ have designed the smart cockpit of their own cars to be’ tall’, but the intelligent display function of traffic lights has not been connected to the operating system that comes with the car." Some car owners admitted to Benwei that at present, Gaode and Baidu rely on the data of floating cars to calculate the countdown seconds of traffic lights, and its accuracy is not high enough. I hope to get more and more accurate road data before opening relevant functions to car owners. "For example, push the status of traffic lights directly to the dashboard or even put them on the car head-up display."

To realize these ideas, resources on one side of the road need to be more open. But in this process, how to ensure the security of public data transaction and use? Xiang Junping introduced that the current car operating system is generally connected to the Internet, while traffic data is connected to the public security intranet, and the two are not connected. "In recent years, China has developed technology in a targeted manner. By building a private network of cellular car networking, it has realized the safe and dynamic interaction of road data between on-board units and roadside units."

Multi-party efforts to build industrial clusters,

Let the car network "be useful and easy to use"

The development of car networking industry is advancing from testing and verification to multi-scenario demonstration application and commercial trial operation, and it is timely to strengthen legislative guidance.

"Decision on Promoting the Development of Vehicle Networking and Intelligent Networked Vehicles" combines the structural needs of industrial development, encourages and supports the upstream and downstream cooperation of the industrial chain, and establishes a multi-level industrial technology innovation system. Experts in the industry pointed out that it is imperative to promote the coordinated development of industrial innovation after realizing the coverage of the entire industrial chain of intelligent networked vehicles.

In terms of building the industrial chain of car networking, all regions and cities in our province have their own strengths. Nanjing has its own comparative advantages in vehicle and vehicle software, Changzhou in power battery and vehicle manufacturing, Wuxi in vehicle networking and smart transportation, Suzhou in intelligent networked vehicle key parts, Yancheng in automobile testing and verification, Xuzhou in construction machinery and other fields. Experts suggest further exploring differentiated development paths and forming regional industrial clusters with their own characteristics and complementary advantages.

National and provincial car networking pilot areas are actively building a complete industrial chain ecology. Since its official opening in August 2022, Wuxi Car Networking Town has gathered more than 100 innovative enterprises such as Bosch Intelligent Networking, Gaoxian Robot and Tianan Zhilian, covering new platforms, intelligent roadsides, intelligent driving, commercial testing and other fields.

In Suzhou High-speed Railway New Town, more than 180 car networking related enterprises gather here. Wang Jiali, Chairman of Pioneer (Suzhou) Digital Industry Investment Co., Ltd. introduced that in recent years, the company has successively attracted a number of key projects, covering more than 30 sub-sectors such as software algorithms, simulation testing and travel services.

Emerging industries need standards to regulate and guide them. The five local standards issued by Suzhou at the end of 2023 focus on low-speed small unmanned sweepers, unmanned express vehicles, cloud control basic platforms, intelligent networked intersections, etc., covering many fields. Qiu Yifei, director of DICT transportation industry of Suzhou Branch of China Mobile Communications Group Jiangsu Co., Ltd., said, "We have made requirements on the basic composition and basic functions of intelligent network junction. For example, the signal light data of intelligent network junction should support viewing real-time light status, countdown seconds, support signal light data distribution, and will continue to improve the standards of construction requirements and management requirements."

"To develop the smart car networking industry, it is necessary to promote the forces of all parties to move in the opposite direction under the guidance of the government." In Qi Yong’s view, to build an intelligent car networking industry system in the province, we must first base ourselves on the key high-tech industrial parks in the province and the national independent innovation demonstration zone in southern Jiangsu, conform to the coordinated development trend of the intelligent car networking industry in our province and the Yangtze River Delta region, and sort out the key core common technologies and key enterprises in the upper, middle and lower reaches of the industrial chain. Specifically, the government should formulate a long-term industrial development plan, compile a technology roadmap, and introduce industrial policies to promote incentives and strengthen guidance; The park should vigorously cultivate and introduce chain owners and backbone enterprises; Enterprises should increase investment in research and development, strengthen key core technology research and development of application scenarios, and promote industrial development by mining typical scenarios; At the industry level, it is necessary to strengthen the cooperation between the upper, middle and lower reaches of the industrial chain, give full play to the advantages of the collaborative research system, and focus on cultivating strategic emerging industry integration clusters to enhance industrial competitiveness.

In 2023, Mazda sold a total of 1.241 million vehicles in the world, and only 97,000 vehicles were sold in the Chinese market, accounting for 7.8%. Assuming, I mean assuming, Mazda’s withdrawal from China does not seem to have any special impact on Mazda. After all, Mazda is indeed a niche brand in China. However, Changan Mazda does not plan to lie down, and recently made a price adjustment to its model CX-30.

Official drop 32,000 yuan, the current CX-30 starting price is only 99,000 yuan

Mazda CX-30 positioning small SUV, the original starting price is 129,900 yuan, the official down after adjustment to 99,000 yuan. However, the entry version is a manual transmission model, the configuration is relatively simple, only equipped with other functions. If the pursuit of a more complete experience, the top model automatic Zunyue type is a more suitable choice, with front and rear radar, a set of more complete driver assistance system, electric trunk, adaptive near and far light, auto front light, induction wipers and other practical functions, but the price has also come to 139,900 yuan, to this price, and other models have entered the consumer’s line of sight, CX-30 may not be able to win.

The price reduction of the Mazda CX-30 was a choice that had to be made. Judging from the sales results, it is currently the last player among the four Mazda models on sale in Changan. It has only sold 1,217 vehicles in the past year, with an average of only 101 vehicles per month. The sense of presence is almost negligible. If you don’t make an effort, you may really have to say goodbye.

The official drop of the CX-30 is nothing more than a copy of last year’s operation of Onxella. At the end of June 2023, Onxella announced the official drop, and the starting price was reduced to 89,900 yuan. The effect was immediate. The monthly sales after the official drop rushed from the original one or two thousand to the highest 8805 vehicles, but this year’s sales performance began to return to the bottom, maintaining the level of more than 2,000 monthly sales.

Sales performance of Mazda models on sale, CX-50 and CX-30 fellow sufferers

At present, Mazda’s best-selling model in China is the Onxella. The sales volume in the last year is 55,700, with an average of nearly 5,000 vehicles per month, which is considered a third-tier player. The CX-5 is second. The sales volume in the last year is 26,500, with an average of more than 2,200 vehicles per month. This car is now also a member of the price reduction camp. At present, the flagship of Changan Mazda’s family, the CX-50, has a very unsatisfactory sales performance. It has sold less than 10,000 vehicles in the past year. In June, it sold only 625 vehicles, which is not much better than the CX-30. It can be described as fellow sufferers.

Mazda China’s new car plan, the EZ6 is on the horizon, will the CX-60 still dare to come?

Although Mazda’s situation in China is relatively marginalized, new products are still being planned. The first is the answer to the current trend of new energy vehicles – the EZ6, which is a mid-range sedan, but it is not the successor. It can be said that it does not matter. The EZ6 provides both pure electric and range extension power, and is regarded as a model on the same platform. The development of domestic new energy leads the world, so there is a phenomenon called "joint venture 2.0". Foreign brands have begun to launch new products on the platform of their own brands. The EZ6 is such a product. I don’t know what the price will be. Can it save Mazda’s decline?

There are also two global models – Mazda CX-90 and CX-60. There is news about them being domestically produced, but the personal feeling is not optimistic. Let’s start with the CX-90, which is a medium and large SUV with high power specifications and positioning. The Mazda brand’s appeal in China is limited, and it only exists in the market of about 100,000 yuan. It is difficult to gain a foothold in the high-end market. As for the CX-60, the positioning is slightly lower, and the possibility of domestic production is higher than that of the CX-90, but it is only possible, because overseas models have been unveiled as early as 2022, and now there is still no sign of road tests in China, which may have been put on hold.

Full text summary

A few years ago, Mazda executives in the UK declared that "Mazda wants to become a luxury brand", which attracted ridicule and ridicule from domestic netizens. If Mazda can really become a luxury brand, it will definitely not be in China. In recent years, Mazda’s sales have fallen again and again, FAW Mazda has been disbanded, and Artez has stopped production. These are all helpless moves under the influence of the general environment. As a propaganda and manipulation manufacturer, Mazda is indeed struggling in the face of today’s consumer atmosphere in the home market, coupled with a not strong brand power. Now it is up to us to see if EZ6 can bring new opportunities to this small manufacturer, and we will wait and see.

IT Home reported on April 24 that during the Lantu Automotive Spring Technical Communication Conference held today, Huawei Smart Car Solutions BU CEO Jin Yuzhi announced the details of the cooperation between the two parties.

Jin Yuzhi said that the model of cooperation between Lantu and Huawei will be equipped with Huawei’s latest ADS 3.0 system and Hongmeng intelligent cockpit. The first model equipped with this solution will be Lantu Dreamer (IT Home Note: MPV models already listed, see the picture below), which will be released in the first half of next year.

Lantu also announced that it will launch a new pure electric SUV model this year. It is reported that the two sides signed a strategic cooperation agreement in January this year, and Lantu’s subsequent models will use more Huawei intelligent related technologies.

Earlier today, Huawei released its new brand "DANGZHOU". Huawei’s DANGZHOU smart car solutions cover chips, hardware, software, and cloud, and released ten new products, including DANGZHOU smart driving, DANGZHOU car cloud, DANGZHOU car control, and Hongmeng cockpit.

Among them, Dry Smart Driving ADS 3.0 adopts a new architecture of 3.0 and is equipped with an omnidirectional anti-collision system CAS 3.0; it supports parking spaces to parking spaces, and parking and driving all scenarios for commercial use.

Huawei said this morning that Huawei has launched the first year of smart driving commercial scale, and new cars such as Dongfeng, Changan, GAC, BAIC, Sailis, Chery, and Jianghuai will be equipped with smart car solutions. Huawei also stressed again that it does not build cars, with the goal of helping car companies build good cars.

In March this year, the State-owned Assets Supervision and Administration Commission of the State Council said that the development of state-owned automobile enterprises in new energy vehicles was not fast enough, and conducted a separate assessment of the new energy automobile business of three central automobile enterprises. These enterprises are the central automobile enterprises directly supervised by the State-owned Assets Supervision and Administration Commission, including FAW Group, Dongfeng Group, and Changan Group. Lu Fang, CEO of Lantu, said that the "separate assessment" policy is a very big encouragement for the company, and the strategic determination and development confidence are more firm. It is also conducive to the company to let go of its hands and feet, work quickly, stimulate innovation vitality, meet user requests, and increase market share.